BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, Chawla YK, Dokmeci AK, Garg H, Ghazinyan H, Hamid S, Kim DJ, Komolmit P, Lata S, Lee GH, Lesmana LA, Mahtab M, Maiwall R, Moreau R, Ning Q, Pamecha V, Payawal DA, Rastogi A, Rahman S, Rela M, Saraya A, Samuel D, Saraswat V, Shah S, Shiha G, Sharma BC, Sharma MK, Sharma K, Butt AS, Tan SS, Vashishtha C, Wani ZA, Yuen MF, Yokosuka O;  APASL ACLF Working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8:453-471. [PMID: 26202751 DOI: 10.1007/s12072-014-9580-2] [Cited by in Crossref: 421] [Cited by in F6Publishing: 377] [Article Influence: 52.6] [Reference Citation Analysis]
Number Citing Articles
1 Teerasarntipan T, Thanapirom K, Chirapongsathorn S, Suttichaimongkol T, Chamroonkul N, Bunchorntavakul C, Siramolpiwat S, Chainuvati S, Sobhonslidsuk A, Leerapun A, Piratvisuth T, Sukeepaisarnjaroen W, Tanwandee T, Treeprasertsuk S. Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study. PLoS ONE 2022;17:e0277959. [DOI: 10.1371/journal.pone.0277959] [Reference Citation Analysis]
2 Li P, Liang X, Luo J, Li J, Xin J, Jiang J, Shi D, Lu Y, Hassan HM, Zhou Q, Hao S, Zhang H, Wu T, Li T, Yao H, Ren K, Guo B, Zhou X, Chen J, He L, Yang H, Hu W, Ma S, Li B, You S, Xin S, Chen Y, Li J. Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: An observational cohort study. The Lancet Regional Health - Western Pacific 2022. [DOI: 10.1016/j.lanwpc.2022.100638] [Reference Citation Analysis]
3 Zhang J, Yu X, Yang F, Sun J, Qiu C, Zheng Y, Zhao W, Yuan S, Zeng D, Long J, Zhu M, Zhang X, Wu J, Ma Z, Zhu H, Su M, Xu J, Li B, Mao R, Su Z. Sustained high expression of BTLA on CD4+ T cell contributes to high rate of bacterial infection and mortality in patients with HBV-related acute-on-chronic liver failure via CD4+ T cell exhaustion.. [DOI: 10.21203/rs.3.rs-2190871/v1] [Reference Citation Analysis]
4 Yin J, Xu X, Pu R, Su H, Wang J, Liu W, Tong J, Chen J, Chen X, Mu X, Zhang H, Zhai X, Liu X, Pang F, Wang Y, Wang H, Cao G, Hu J. A Lower HCC Incidence in Chronic HBV-Infected Patients Recovered from Acute-on-Chronic Liver Failure: A Prospective Cohort Study. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5873002] [Reference Citation Analysis]
5 Perez Ruiz de Garibay A, Kortgen A, Leonhardt J, Zipprich A, Bauer M. Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care 2022;26:289. [DOI: 10.1186/s13054-022-04163-1] [Reference Citation Analysis]
6 Chu J, Yang Y, Liu Y, Pei L, Zhou Y, Lu T, Zhang Y, Hu H, Li Y, Yang F, Lin S. Bacterial Infections Confer a Risk of Progression to Acute-on-Chronic Liver Failure in Patients with HBV-Related Compensated Cirrhosis During Severe Hepatitis Flares. Infect Dis Ther 2022. [PMID: 36151452 DOI: 10.1007/s40121-022-00695-9] [Reference Citation Analysis]
7 Ebik B, Ekin N, Bacaksiz F, Kilic J. Kronik karaciğer hastalarında COVID-19; siroz hastaları için büyük tehlike. ETD 2022. [DOI: 10.19161/etd.1166881] [Reference Citation Analysis]
8 Zhang L, Hu J, Gou C, Jin H, Zhang C, Liu Y, Wang Y, Wang X, Yokota S. Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure. Mediators of Inflammation 2022;2022:1-13. [DOI: 10.1155/2022/7794890] [Reference Citation Analysis]
9 Jiang X, Chai S, Huang Y, Huang Z, Tan W, Gao Y, Lu X, Meng Z, Zhou H, Kong W, Tang X, Tang Y, Qi T, Liao C, Gan Q, Xiang X, Zhang Y, Wang S, Chen Y, Chen J. Design for a Multicentre Prospective Cohort for the Assessment of Platelet Function in Patients with Hepatitis-B-Virus-Related Acute-on-Chronic Liver Failure. Clin Epidemiol 2022;14:997-1011. [PMID: 36042872 DOI: 10.2147/CLEP.S376068] [Reference Citation Analysis]
10 Wang H, Yin YP, Wang ZL, Qian Y, Fan YC, Liu HH, Wang K. Hypermethylation of thymosin β4 predicts a poor prognosis for patients with acute-on-chronic hepatitis B liver failure. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00191-6. [PMID: 36041971 DOI: 10.1016/j.hbpd.2022.08.005] [Reference Citation Analysis]
11 Qiang R, Liu X, Xu J. The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis. Front Immunol 2022;13:935160. [DOI: 10.3389/fimmu.2022.935160] [Reference Citation Analysis]
12 Abbas N, Rajoriya N, Elsharkawy AM, Chauhan A. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? Expert Rev Gastroenterol Hepatol 2022. [PMID: 35786130 DOI: 10.1080/17474124.2022.2097070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Peng H, Zhang Q, Luo L, Lei S, Xiong T, Long L, Xiong Y, Zhang L, Zheng J, Luo X. A prognostic model of acute-on-chronic liver failure based on sarcopenia. Hepatol Int 2022. [PMID: 35771410 DOI: 10.1007/s12072-022-10363-2] [Reference Citation Analysis]
14 Kumar Yadav D, Kumar Yadav R, Liang T. Acute Decompensated Liver: When to Transplant? Controversies in Liver Transplantation - Recent Challenges and Future Perspectives [Working Title] 2022. [DOI: 10.5772/intechopen.105350] [Reference Citation Analysis]
15 Toshima T, Harada N, Itoh S, Morita K, Nagao Y, Kurihara T, Tomino T, Kosai-Fujimoto Y, Morinaga A, Tomiyama T, Yoshizumi T. Outcomes of living-donor liver transplantation for acute-on-chronic liver failure based on newly proposed criteria in Japan. Clin Transplant 2022;:e14739. [PMID: 35642940 DOI: 10.1111/ctr.14739] [Reference Citation Analysis]
16 Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, Inoue K, Genda T, Takikawa Y, Takami T, Kato N, Abe M, Abe R, Inui A, Ohira H, Kasahara M, Chayama K, Hasegawa K, Tanaka A. Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan. Hepatol Res 2022;52:417-21. [PMID: 35591813 DOI: 10.1111/hepr.13763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhou Z, Yi J, Li Q, Hu W, Chen G, Si Z, Li J, Granito A. Factors Prognostic of Survival in Liver Transplant Recipients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-10. [DOI: 10.1155/2022/6390809] [Reference Citation Analysis]
18 Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology 2022;75:1194-203. [PMID: 34822189 DOI: 10.1002/hep.32255] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
19 Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, Inoue K, Genda T, Takikawa Y, Takami T, Kato N, Abe M, Abe R, Inui A, Ohira H, Kasahara M, Chayama K, Hasegawa K, Tanaka A. Diagnostic Criteria for Acute-on-Chronic Liver Failure and Related Disease Conditions in Japan. Acta hepatologica Japonica 2022;63:219-223. [DOI: 10.2957/kanzo.63.219] [Reference Citation Analysis]
20 Wang L, Zhu S, Liu Y, Zheng L, Xu W, Luo Q, Zhang Y, Deng H, Li X, Xie C, Peng L. Prognostic value of decline in model for end-stage liver disease score and hepatic encephalopathy in hepatitis B-related acute-on-chronic liver failure patients treated with plasma exchange. Scandinavian Journal of Gastroenterology. [DOI: 10.1080/00365521.2022.2063032] [Reference Citation Analysis]
21 Wang X, Zhong Y, Zhang R, Chen Y, Wang M, Lv C, Mao D. Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure. Evid Based Complement Alternat Med 2022;2022:5652172. [PMID: 35399641 DOI: 10.1155/2022/5652172] [Reference Citation Analysis]
22 Bai W, Yao C, Mao D, Wu J, Wang K, Wei H, Huang Z, Shi Q, Wang N. The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. J Healthc Eng 2022;2022:3139929. [PMID: 35368957 DOI: 10.1155/2022/3139929] [Reference Citation Analysis]
23 Wang L, Xu W, Li X, Chen D, Zhang Y, Chen Y, Wang J, Luo Q, Xie C, Peng L. Long-term prognosis of patients with hepatitis B virus–related acute-on-chronic liver failure: a retrospective study. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02239-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu W, Pu Y, Zhu C, Qin A. Establishment of a scoring model for early diagnosis of infection associated with liver failure. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100713] [Reference Citation Analysis]
25 Buccheri S, Da BL. Hepatorenal Syndrome. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.002] [Reference Citation Analysis]
26 Jain A, Sharma BC. Reply. Hepatology 2022;75:1066-7. [PMID: 34951718 DOI: 10.1002/hep.32305] [Reference Citation Analysis]
27 Sahu D, Bishwal SC, Malik MZ, Sahu S, Kaushik SR, Sharma S, Saini E, Arya R, Rastogi A, Sharma S, Sen S, Singh RKB, Liu C, Nanda RK, Panda AK. Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis. Front Cell Dev Biol 2022;10:845457. [DOI: 10.3389/fcell.2022.845457] [Reference Citation Analysis]
28 Zakareya T, Akl M, Shibl S, El-mazaly M, Abdel-razek W. Utility of prognostic scores in predicting short-term mortality in patients with acute-on-chronic liver failure. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00183-2] [Reference Citation Analysis]
29 Chirapongsathorn S, Teerasarntipan T, Tipchaichatt K, Suttichaimongkol T, Chamroonkul N, Bunchorntavakul C, Siramolpiwat S, Chainuvati S, Sobhonslidsuk A, Leerapun A, Piratvisuth T, Sukeepaisarnjaroen W, Tanwandee T, Treeprasertsuk S. Acute‐on‐chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population. JGH Open. [DOI: 10.1002/jgh3.12719] [Reference Citation Analysis]
30 Kondo T, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Ogasawara S, Ooka Y, Nakamoto S, Chiba T, Arai M, Kato J, Kuboki S, Ohtsuka M, Kato N. Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma. PLoS One 2022;17:e0261619. [PMID: 35085277 DOI: 10.1371/journal.pone.0261619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chirapongsathorn S, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, Chaiprasert A, Phaosawasdi K, Treeprasertsuk S. Health care burden and mortality of acute on chronic liver failure in Thailand: a nationwide population-based cohort study. BMC Health Serv Res 2022;22:156. [PMID: 35125103 DOI: 10.1186/s12913-022-07574-6] [Reference Citation Analysis]
32 Tian Z, Yao N, Wu Y, Wang F, Zhao Y. Association between plasma level of superoxide dismutase and survival of patients with acute-on-chronic liver failure. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02126-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Xiao F, Wang HW, Hu JJ, Tao R, Weng XX, Wang P, Wu D, Wang XJ, Yan WM, Xi D, Luo XP, Wan XY, Ning Q. Fibrinogen-like protein 2 deficiency inhibits virus-induced fulminant hepatitis through abrogating inflammatory macrophage activation. World J Gastroenterol 2022; 28(4): 479-496 [DOI: 10.3748/wjg.v28.i4.479] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 García-rueda JE, Londoño-garcía R, Marín-cuartas T, Hernández-abaunza JE, Osorio-rico S, Bermúdez-flórez AM, Restrepo-gutiérrez JC. Falla hepática aguda sobre crónica: análisis de una serie de casos y revisión de la literatura. Hepatología 2022. [DOI: 10.52784/27112330.149] [Reference Citation Analysis]
35 Dong Y, Sun D, Wang Y, Du Q, Zhang Y, Han R, Teng M, Zhang T, Shi L, Zheng G, Dong Y, Wang T. Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure. BMC Infect Dis 2022;22:23. [PMID: 34983426 DOI: 10.1186/s12879-021-07018-2] [Reference Citation Analysis]
36 Kaushal K, Gupta V, Goswami P, Agarwal S, Sharma S, Das P, Yadav R, Anand A, Sonika U, Gunjan D, Saraya A. Acute Variceal Bleed in Cirrhosis is Associated With Reversible Changes in Tight Junction Protein Expression in the Intestine: A Proof-of-Concept Study. Journal of Clinical and Experimental Hepatology 2022;12:89-100. [DOI: 10.1016/j.jceh.2021.03.009] [Reference Citation Analysis]
37 Jalan R, Perricone G. Acute-on-Chronic Liver Failure: Definition and Prognosis. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_3] [Reference Citation Analysis]
38 Gambato M, Ferrarese A. Indications to Liver Transplantation for Liver Cirrhosis. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_2] [Reference Citation Analysis]
39 Squires JE, McKiernan PJ, Squires RH. Acute Liver Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. Pediatrics 2022;149:S59-65. [PMID: 34970684 DOI: 10.1542/peds.2021-052888I] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Ginanni Corradini S, Ferri F. Referral to the Liver Transplant Center. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_35] [Reference Citation Analysis]
41 Dandu H, Kumar V, Goel A, Khetan D, Chandra T, Bharti V. A preliminary experience of plasma exchange in liver failure. Asian J Transfus Sci 2022;16:212. [DOI: 10.4103/ajts.ajts_115_21] [Reference Citation Analysis]
42 Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut 2022;71:148-55. [PMID: 33436495 DOI: 10.1136/gutjnl-2020-322161] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 26.0] [Reference Citation Analysis]
43 Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J. aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure. IJGM 2022;Volume 15:407-15. [DOI: 10.2147/ijgm.s343457] [Reference Citation Analysis]
44 Angraje S, Sekar M, Mishra B, Matcha J. Outcome of Plasma Exchange in Acute Liver Failure due to Yellow Phosphorus Poisoning: A Single-center Experience. Indian J Crit Care Med 2021;25:1020-5. [PMID: 34963720 DOI: 10.5005/jp-journals-10071-23971] [Reference Citation Analysis]
45 Wu J, Shi C, Sheng X, Xu Y, Zhang J, Zhao X, Yu J, Shi X, Li G, Cao H, Li L. Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China. J Clin Transl Hepatol 2021;9:828-37. [PMID: 34966646 DOI: 10.14218/JCTH.2020.00117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
46 Yu X, Lu Y, Sun S, Tu H, Xu X, Gong K, Yao J, Shi Y, Sheng J. Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report. J Clin Transl Hepatol 2021;9:838-49. [PMID: 34966647 DOI: 10.14218/JCTH.2021.00005] [Reference Citation Analysis]
47 Li Y, Kong Y, Shi K, Huang Y, Zhang Q, Zhu B, Zeng H, Wang X. CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure. Front Med (Lausanne) 2021;8:762296. [PMID: 34938747 DOI: 10.3389/fmed.2021.762296] [Reference Citation Analysis]
48 Li S, Zhang X, Li Q, Lv B, Zhang Y, Jia J, Yue X, Lu W. Development and validation of the nomogram based on INR and eGFR for estimation of mortality in patients with acute-on-chronic hepatitis B liver failure. BMC Gastroenterol 2021;21:474. [PMID: 34911462 DOI: 10.1186/s12876-021-02054-3] [Reference Citation Analysis]
49 Xu X, Li C, Chen J, Liu X, Su H, Tong J, Hu J. Relationship Between Platelet to White Blood Cell Ratio and 30-Day Prognosis of Patients with Acute-on-Chronic Liver Failure. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.118640] [Reference Citation Analysis]
50 Wang Y, Dong F, Sun S, Wang X, Zheng X, Huang Y, Li B, Gao Y, Qian Z, Liu F, Lu X, Liu J, Ren H, Zheng Y, Yan H, Deng G, Qiao L, Zhang Y, Gu W, Xiang X, Zhou Y, Xu B, Hou Y, Zhang Q, Xiong Y, Zou C, Chen J, Huang Z, Jiang X, Qi T, Luo S, Chen Y, Gao N, Liu C, Yuan W, Mei X, Li J, Li T, Zheng R, Zhou X, Zhang W, Li H, Meng Z. Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis. Front Med (Lausanne) 2021;8:762291. [PMID: 34869468 DOI: 10.3389/fmed.2021.762291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Zhang Z, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Ma K, Zhang M, Luo X, Chen T, Ning Q. Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection. Hepatol Int 2021. [PMID: 34855105 DOI: 10.1007/s12072-021-10268-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Ballester MP, Sittner R, Jalan R. Alcohol and Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Khanam A, Kottilil S. Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management. Front Med (Lausanne) 2021;8:752875. [PMID: 34820395 DOI: 10.3389/fmed.2021.752875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Thanapirom K, Teerasarntipan T, Treeprasertsuk S, Choudhury A, Sahu MK, Maiwall R, Pamecha V, Moreau R, Al Mahtab M, Chawla YK, Devarbhavi H, Yu C, Ning Q, Amarapurkar D, Eapen CE, Hamid SS, Butt AS, Kim DJ, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Yuen MF, Chan A, Lau G, Jia J, Rahman S, Sharma BC, Yokosuka O, Sarin SK; APASL ACLF Working Party. Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure. Hepatol Int 2021. [PMID: 34822057 DOI: 10.1007/s12072-021-10266-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
55 Wang Y, Wu F, Chen C, Xu L, Lin W, Huang C, Yang Y, Wu S, Qi J, Cao H, Li G, Hong M, Zhu H. Soluble urokinase plasminogen activator receptor is associated with short-term mortality and enhanced reactive oxygen species production in acute-on-chronic liver failure. BMC Gastroenterol 2021;21:429. [PMID: 34789156 DOI: 10.1186/s12876-021-02006-x] [Reference Citation Analysis]
56 Sun J, Guo H, Yu X, Zhu H, Zhang X, Yang J, Wang J, Qian Z, Shen Z, Mao R, Zhang J. A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure. BMC Gastroenterol 2021;21:422. [PMID: 34758747 DOI: 10.1186/s12876-021-02007-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Hossain SMS, Mahtab MA, Das DC, Noor-E-Alam SM, Mamun AA, Khan MSI, Akbar SMF, Rahman MZ, Rahman S. Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure. J Family Med Prim Care 2021;10:2642-5. [PMID: 34568149 DOI: 10.4103/jfmpc.jfmpc_2299_20] [Reference Citation Analysis]
58 Gambino C, Piano S, Angeli P. Acute-on-Chronic Liver Failure in Cirrhosis. J Clin Med 2021;10:4406. [PMID: 34640424 DOI: 10.3390/jcm10194406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
59 Wong F, Reddy KR, Tandon P, Lai JC, Jagarlamudi N, Weir V, Kok B, Kalainy S, Srisengfa YT, Albhaisi S, Reuter B, Acharya C, Shaw J, Thacker LR, Bajaj JS. The Prediction of In-Hospital Mortality in Decompensated Cirrhosis with Acute-on-Chronic Liver Failure. Liver Transpl 2021. [PMID: 34564944 DOI: 10.1002/lt.26311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
60 Diaz JM, Mauro E, Gutierrez-acevedo MN, Gadano A, Marciano S. Liver Transplantation in Patients with Acute-onChronic Liver Failure: Challenging the Limits. EMJ. [DOI: 10.33590/emj/21-00040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Khatua CR, Sahu SK, Meher D, Nath G, Mohapatra A, Thakur B, Singh SP. Admission Serum Urea is a Better Predictor of Mortality than Creatinine in Patients With Acute-On-Chronic Liver Failure and Acute Kidney Injury. J Clin Exp Hepatol 2021;11:565-72. [PMID: 34511817 DOI: 10.1016/j.jceh.2020.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Singal AK, Wong RJ, Jalan R, Asrani S, Kuo YF. Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant. Clin Transplant 2021;35:e14479. [PMID: 34510550 DOI: 10.1111/ctr.14479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
63 Rui F, Yang H, Guo Z, Ge Z, Hu X, Zhang L, Xue Q, Chen H, Xu Y, Tan M, Qin C, He Z, Li J. Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients. J Viral Hepat 2021;28:1719-28. [PMID: 34496100 DOI: 10.1111/jvh.13611] [Reference Citation Analysis]
64 Chen D, Qian Z, Su H, Meng Z, Lv J, Huang Y, Gao Y, Liu J, Zhao C, Gao H, Chen Y, Xia J, Peng L, Han T, Li H, Zheng X, Wang X, Lu X, Shi Y, Hu J, Chen J. Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options. Infect Dis Ther 2021;10:2525-38. [PMID: 34468963 DOI: 10.1007/s40121-021-00524-5] [Reference Citation Analysis]
65 Nautiyal N, Maheshwari D, Tripathi DM, Kumar D, Kumari R, Gupta S, Sharma S, Mohanty S, Parasar A, Bihari C, Biswas S, Rastogi A, Maiwall R, Kumar A, Sarin SK. Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction. Hepatol Int 2021. [PMID: 34435344 DOI: 10.1007/s12072-021-10244-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Li S, Li H, Cao Y, Geng H, Ren F, Li K, Dai C, Li N. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma. Medicine (Baltimore) 2021;100:e26474. [PMID: 34397869 DOI: 10.1097/MD.0000000000026474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Long L, Li H, Deng G, Wang X, Lu S, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Ren H, Shang J, Li H, Wang S, Zheng Y, Yan H, Yin S, Tan W, Zhang Q, Zheng X, Chen J, Luo S, Zhao J, Yuan W, Li T, Zheng R, Liu J, Liu X, Gu W, Li S, Mei X, Chen R, Huang Y. Impact of Hepatic Encephalopathy on Clinical Characteristics and Adverse Outcomes in Prospective and Multicenter Cohorts of Patients With Acute-on-Chronic Liver Diseases. Front Med (Lausanne) 2021;8:709884. [PMID: 34409052 DOI: 10.3389/fmed.2021.709884] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Zhang K, Sun H, Cao H, Jia Y, Shu X, Cao H, Zhang Y, Yang X. The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis. Stem Cell Res Ther 2021;12:466. [PMID: 34416908 DOI: 10.1186/s13287-021-02544-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Vijayaraghavan R, Maiwall R, Arora V, Choudhary A, Benjamin J, Aggarwal P, Jamwal KD, Kumar G, Joshi YK, Sarin SK. Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients. Dig Dis Sci 2021. [PMID: 34392492 DOI: 10.1007/s10620-021-07185-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Su H, Tong J, Liu X, Li C, Chen J, Xu X, Guan C, Peng Y, Yan L, Ning P, Li H, Zhang L, Hu J. Characteristics and outcome of nosocomial bloodstream infection in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol 2021;33:83-8. [PMID: 32118849 DOI: 10.1097/MEG.0000000000001699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Schacher FC, Martins Pezzi da Silva A, Silla LMDR, Álvares-da-Silva MR. Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial. Can J Gastroenterol Hepatol 2021;2021:3662776. [PMID: 34395335 DOI: 10.1155/2021/3662776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
72 Xiao L, Tang S, Zhang L, Ma S, Zhao Y, Zhang F, Xie Z, Li L. Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. Front Med (Lausanne) 2021;8:657076. [PMID: 34395462 DOI: 10.3389/fmed.2021.657076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Karvellas CJ, Francoz C, Weiss E. Liver Transplantation in Acute-on-chronic Liver Failure. Transplantation 2021;105:1471-81. [PMID: 33208692 DOI: 10.1097/TP.0000000000003550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
74 Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, Deshmukh H, Cua IHY, Lesmana CRA, Al Meshtab M, Kage M, Chaiteeraki R, Treeprasertsuk S, Giri S, Punamiya S, Paradis V, Qi X, Sugawara Y, Abbas Z, Sarin SK. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021;15:531-67. [PMID: 34240318 DOI: 10.1007/s12072-021-10189-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
75 Xiao LL, Wu XX, Chen JJ, Yan D, Shi DY, Huang JR, Xu XW, Li LJ. Progress in hepatitis B virus-related acute-on-chronic liver failure treatment in China: A large, multicenter, retrospective cohort study using a propensity score matching analysis. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00119-3. [PMID: 34303609 DOI: 10.1016/j.hbpd.2021.05.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
76 Jiao Y, Lu W, Xu P, Shi H, Chen D, Chen Y, Shi H, Ma Y. Hepatocyte-derived exosome may be as a biomarker of liver regeneration and prognostic valuation in patients with acute-on-chronic liver failure. Hepatol Int 2021;15:957-69. [PMID: 34232468 DOI: 10.1007/s12072-021-10217-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
77 Wu D, Zhang L, Ma S, Zhao Y, Chen R, Zhang F, Liu Q, Xu X, Xie Z. Low Growth Hormone Levels Predict Poor Outcome of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Front Med (Lausanne) 2021;8:655863. [PMID: 34295909 DOI: 10.3389/fmed.2021.655863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Malakar D, Mahtab MA, Manik AH, Alam SMNE, Das DC, Mamun AA, Khan MSI, Rahman Z, Rahman S, Akbar SMF. Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure. J Family Med Prim Care 2021;10:2381-5. [PMID: 34322442 DOI: 10.4103/jfmpc.jfmpc_2302_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Durand F, Roux O, Weiss E, Francoz C. Acute-on-chronic liver failure: Where do we stand? Liver Int 2021;41 Suppl 1:128-36. [PMID: 34155793 DOI: 10.1111/liv.14855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Lai RM, Chen TB, Hu YH, Wu G, Zheng Q. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol 2021; 27(23): 3372-3385 [PMID: 34163118 DOI: 10.3748/wjg.v27.i23.3372] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
81 Chen JF, Weng WZ, Huang M, Peng XH, He JR, Zhang J, Xiong J, Zhang SQ, Cao HJ, Gao B, Lin DN, Gao J, Gao ZL, Lin BL. Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure. Front Med (Lausanne) 2021;8:692669. [PMID: 34222294 DOI: 10.3389/fmed.2021.692669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Zhang ZQ, He G, Luo ZW, Cheng CC, Wang P, Li J, Zhu MG, Ming L, He TS, Ouyang YL, Huang YY, Wu XL, Ye YN. Individual mortality risk predictive system of patients with acute-on-chronic liver failure based on a random survival forest model. Chin Med J (Engl) 2021;134:1701-8. [PMID: 34133353 DOI: 10.1097/CM9.0000000000001539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Feng R, Guo X, Kou Y, Xu X, Hong C, Zhang W, An Y, Philips CA, Mancuso A, Qi X. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis. Postgrad Med 2021;133:626-38. [PMID: 33993838 DOI: 10.1080/00325481.2021.1930560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
84 Gao S, Fan YC, Han LY, Wang K. Serum exosomal long noncoding RNA nuclear-enriched abundant transcript 1 predicts 90-day mortality in acute-on-chronic hepatitis B liver failure. Expert Rev Clin Immunol 2021;17:789-97. [PMID: 34057878 DOI: 10.1080/1744666X.2021.1933442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Fu X, Cheng D, Ouyang Y, Li Y, Li R, Peng S, Fu L. Integrated Analysis of Long Noncoding RNA Expression Profiles in Acute-on-Chronic Liver Failure. Biomed Res Int 2021;2021:5387856. [PMID: 34104647 DOI: 10.1155/2021/5387856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Engelmann C, Martino VD, Kerbert AJC, Weil-Verhoeven D, Aehling NF, Herber A, Thévenot T, Berg T. The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure. Semin Liver Dis 2021;41:298-307. [PMID: 33992029 DOI: 10.1055/s-0041-1723034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
87 Zhang Z, Ma K, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Zhang M, Luo X, Chen T, Ning Q. Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Infect Dis Ther 2021;10:1347-61. [PMID: 33991329 DOI: 10.1007/s40121-021-00454-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
88 Varma A, Abraham SC, Mehta RS, Saini NY, Honhar M, Rashid M, Chen J, Srour SA, Bashir Q, Rondon G, Oran B, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Marin D, Khouri IF, Ciurea SO, Qazilbash MH, Rezvani K, Anderlini P, Andersson BS, Shpall EJ, Champlin RE, Popat UR. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv 2020;4:1296-306. [PMID: 32236526 DOI: 10.1182/bloodadvances.2019000638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Wang YC, Yong CC, Lin CC, Alam H, Naseer F, Lin YH, Yeh CH, Wang SH, Lin TS, Lin TL, Lee WF, Chan YC, Wang CC, Chen CL. Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute-on-Chronic Liver Failure. Liver Transpl 2021. [PMID: 33977657 DOI: 10.1002/lt.26096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Chen S, Li H, Lin X, Hu S, Zhang Z. Development and Evaluation of Nutrition Screening Tool in Patients with Hepatitis B-Related Cirrhosis: A Cross-Sectional Study. Risk Manag Healthc Policy 2021;14:1823-31. [PMID: 33986619 DOI: 10.2147/RMHP.S299428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Ma S, Xie Z, Zhang L, Yang Y, Jiang H, Ouyang X, Zhao Y, Liu Q, Xu X, Li L. Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF. Front Mol Biosci 2021;8:657631. [PMID: 33996909 DOI: 10.3389/fmolb.2021.657631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Chen Y, Sun J, Fan X, Wang X, Zeng L, Zhang X, Zhang K, Li N, Han Q, Liu Z. Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure. Front Pharmacol 2021;12:648736. [PMID: 33967787 DOI: 10.3389/fphar.2021.648736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Weng F. The use of APASL consensus for the diagnosis of hepatitis B virus-related acute-on-chronic liver failure. Liver Int 2021;41:1437. [PMID: 33827147 DOI: 10.1111/liv.14890] [Reference Citation Analysis]
94 Yao X, Yu H, Fan G, Xiang H, Long L, Xu H, Wu Z, Chen M, Xi W, Gao Z, Liu C, Gong W, Yang A, Sun K, Yu R, Liang J, Xie B, Sun S. Impact of the Gut Microbiome on the Progression of Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Front Cell Infect Microbiol 2021;11:573923. [PMID: 33889550 DOI: 10.3389/fcimb.2021.573923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
95 Chen L, Zhang J, Lu T, Cai J, Zheng J, Yao J, Yi S, Li H, Chen G, Zhao H, Zhang Y, Yang Y. A nomogram to predict survival in patients with acute-on-chronic hepatitis B liver failure after liver transplantation. Ann Transl Med 2021;9:555. [PMID: 33987253 DOI: 10.21037/atm-20-6180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Zhou X, Li Y, Ji Y, Liu T, Zhao N, He J, Yao J. PD-1 Involvement in Peripheral Blood CD8+ T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure. J Clin Transl Hepatol 2021;9:283-90. [PMID: 34221914 DOI: 10.14218/JCTH.2020.00142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Borzio M, Dionigi E. Acute on Chronic Liver Failure: Role of the Bacterial Infections. Liver Pathology 2021. [DOI: 10.5772/intechopen.93440] [Reference Citation Analysis]
98 Samuel D. Systemic inflammation and liver cirrhosis complications: Driving or secondary event? How to square the circle? J Hepatol 2021;74:508-10. [PMID: 33478857 DOI: 10.1016/j.jhep.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
99 Chiriac S, Stanciu C, Singeap AM, Sfarti CV, Cuciureanu T, Trifan A. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acute-on-chronic liver failure. Turk J Gastroenterol 2020;31:868-76. [PMID: 33625999 DOI: 10.5152/tjg.2020.19838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
100 Maiwall R, Bajpai M, Choudhury AK, Kumar A, Sharma MK, Duan Z, Yu C, Hu J, Ghazinian H, Ning Q, Ma K, Lee GH, Lim SG, Shah S, Kalal C, Dokmeci A, Kumar G, Jain P, Rao Pasupuleti SS, Paulson I, Kumar V, Sarin SK; AARC working Party. Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: A propensity-score matched study from AARC. Liver Int 2021;41:1083-96. [PMID: 33529450 DOI: 10.1111/liv.14806] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
101 Wang F, Sun W, Xiao Q, Liang C, Jiang S, Lian Y, Shao J, Tan S, Zheng S. Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2021;100:e24075. [PMID: 33592861 DOI: 10.1097/MD.0000000000024075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
102 Khatua CR, Sahu SK, Meher D, Nath G, Singh SP. Acute kidney injury in hospitalized cirrhotic patients: Risk factors, type of kidney injury, and survival. JGH Open 2021;5:199-206. [PMID: 33553656 DOI: 10.1002/jgh3.12467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
103 Banc-Husu AM, Neighbors K, Rychlik K, Mohammad S, Harris ZL, Alonso EM. Admission Characteristics Identify Risk of Pediatric Acute-on-Chronic Liver Failure. J Pediatr Gastroenterol Nutr 2020;70:783-8. [PMID: 32141996 DOI: 10.1097/MPG.0000000000002695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
104 Haque MN, Al-Mahtab M, Das DC, Mohammad NS, Mamun AA, Khan MSI, Akbar SM, Rahman S. Effect of Granulocyte Colony-stimulating Factor and Erythropoietin on Patients with Acute-on-chronic Liver Failure. Euroasian J Hepatogastroenterol 2020;10:64-7. [PMID: 33511067 DOI: 10.5005/jp-journals-10018-1330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Tong L, Hu XG, Huang F, Huang SW, Li LF, Tang ZX, Yao JY, Xu JH, Zhu YP, Chen YH, He XS, Guan XD, Cai C. Clinical Impacts and Outcomes With Possible Donor-Derived Infection in Infected Donor Liver Transplantation: A Single-Center Retrospective Study in China. J Infect Dis 2020;221:S164-73. [PMID: 32176783 DOI: 10.1093/infdis/jiz591] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
106 Rueschenbaum S, Ciesek S, Queck A, Widera M, Schwarzkopf K, Brüne B, Welsch C, Wedemeyer H, Zeuzem S, Weigert A, Lange CM. Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure. Front Immunol 2020;11:534731. [PMID: 33574809 DOI: 10.3389/fimmu.2020.534731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
107 Du L, Ma Y, Zhou S, Chen F, Xu Y, Wang M, Lei X, Feng P, Tang H, Bai L. A prognostic score for patients with acute-on-chronic liver failure treated with plasma exchange-centered artificial liver support system. Sci Rep 2021;11:1469. [PMID: 33446902 DOI: 10.1038/s41598-021-81019-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Qiao L, Wang X, Deng G, Huang Y, Chen J, Meng Z, Zheng X, Shi Y, Qian Z, Liu F, Gao Y, Lu X, Liu J, Gu W, Zhang Y, Wang T, Wu D, Dong F, Sun X, Li H. Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study. BMJ Open 2021;11:e037793. [PMID: 33419900 DOI: 10.1136/bmjopen-2020-037793] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
109 Yang F, Liu Y, Zeng B, Chu J, Hu H, Yang Y, Chen H, Tian C, Li Y, Lin S. Noninvasive assessment of liver fibrosis for predicting acute-on-chronic liver failure in patients with chronic hepatitis B. Hepatol Int 2021;15:593-601. [PMID: 33389677 DOI: 10.1007/s12072-020-10106-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
110 Gavrilenko DI, Silivontchik N. Translocation of gut microbiota in liver cirrhosis: mechanisms, clinical significance, and markers. CMAC 2021;23:147-160. [DOI: 10.36488/cmac.2021.2.147-160] [Reference Citation Analysis]
111 Cao Q, Yu C. Diagnosis of Liver Failure. Artificial Liver 2021. [DOI: 10.1007/978-981-15-5984-6_10] [Reference Citation Analysis]
112 Liu H, Li Y, Gao F, Meng P, Yu H, Wu T, Zhou Y, Jiang Y, Wang X. Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Dis Markers 2020;2020:8814841. [PMID: 33381244 DOI: 10.1155/2020/8814841] [Reference Citation Analysis]
113 Passi NN, Mcphail MJ. The patient with cirrhosis in the intensive care unit and the management of acute-on-chronic liver failure. Journal of the Intensive Care Society 2022;23:78-86. [DOI: 10.1177/1751143720978849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Jia L, Xue R, Zhu Y, Zhao J, Li J, He WP, Wang XM, Duan ZH, Ren MX, Liu HX, Xing HC, Meng QH. The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial. BMC Med 2020;18:383. [PMID: 33287816 DOI: 10.1186/s12916-020-01814-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
115 Trebicka J, Bork P, Krag A, Arumugam M. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Nat Rev Gastroenterol Hepatol 2021;18:167-80. [PMID: 33257833 DOI: 10.1038/s41575-020-00376-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 21.0] [Reference Citation Analysis]
116 Jing J, Sang XX, You SL, Zhu B, Cui YF, Li CY, Wang ZX, Zhao X, Liu XY, Tian M, Ren YB, Yu SM, Xiao XH, Wang JB, Niu M, Wang RL. Metabolomic profiles of breath odor compounds for prognostic prediction in patients with acute-on-chronic liver failure: A pilot study. Hepatol Res 2021;51:490-502. [PMID: 33227168 DOI: 10.1111/hepr.13594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Liu F, Zou Z, Shen L, Wu W, Luo J, Lankford S, Yang Y, Huang H, You S, Zhu B, Li J, Mu J, Zhang Y, Xin S. A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure. Sci Rep 2020;10:20176. [PMID: 33214662 DOI: 10.1038/s41598-020-77235-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
118 Lu CY, Chen CL, Ho CM, Hsiao CY, Wu YM, Ho MC, Lee PH, Hu RH. Dynamic Prognostication in Transplant Candidates with Acute-on-Chronic Liver Failure. J Pers Med 2020;10:E230. [PMID: 33203142 DOI: 10.3390/jpm10040230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
119 Chen J, Huang ZB, Li H, Zheng X, Chen JJ, Wang XB, Qian ZP, Liu XX, Fan XG, Hu XW, Liao CJ, Long LY, Huang Y. Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study. Infect Dis Ther 2021;10:281-90. [PMID: 33146854 DOI: 10.1007/s40121-020-00362-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
120 Steiner-Temnykh L, Dakhoul L, Slaven J, Nephew L, Patidar KR, Orman E, Desai AP, Vilar-Gomez E, Kubal C, Ekser B, Chalasani N, Ghabril M. Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation. Ann Transplant 2020;25:e926453. [PMID: 33139688 DOI: 10.12659/AOT.926453] [Reference Citation Analysis]
121 Kumar M, Kainth S, Kumar S, Bhardwaj A, KumarAggarwal H, Maiwall R, Jamwal KD, Shasthry SM, Jindal A, Choudhary A, Anand L, Dhamija RM, Chibbar G, Chander Sharma B, Sarin SK. Prevalence of and Factors Associated with Sleep-Wake Abnormalities in Patients with Cirrhosis. J Clin Exp Hepatol 2021;11:453-65. [PMID: 34276152 DOI: 10.1016/j.jceh.2020.10.006] [Reference Citation Analysis]
122 Mu X, Tong J, Xu X, Chen J, Su H, Liu X, Pang F, Zhai X, Wang L, Wang Y, Guan C, Wang F, Hu J. World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol 2021;45:101548. [PMID: 33554865 DOI: 10.1016/j.clinre.2020.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
123 Kong LN, Yao Y, Li L, Zhao QH, Wang T, Li YL. Psychological distress and self-management behaviours among patients with chronic hepatitis B receiving oral antiviral therapy. J Adv Nurs 2021;77:266-74. [PMID: 33074555 DOI: 10.1111/jan.14610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
124 Claude C, Deep A, Kneyber M, Siddiqui S, Renolleau S, Morin L, Jacquemin E, Teglas JP, Gajdos V, Tissières P, Durand P; ESPNIC liver failure, support working group. pCLIF-SOFA is a reliable outcome prognostication score of critically ill children with cirrhosis: an ESPNIC multicentre study. Ann Intensive Care 2020;10:137. [PMID: 33052510 DOI: 10.1186/s13613-020-00753-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Li M, Guo Z, Zhang D, Xu X, Romeiro FG, Mancuso A, Zhang J, Feng R, Zhou X, Hong C, Qi X. Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis. Gastroenterol Res Pract 2020;2020:4019289. [PMID: 33029132 DOI: 10.1155/2020/4019289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Arora A, Kumar A, Prasad N, Duseja A, Acharya SK, Agarwal SK, Aggarwal R, Anand AC, Bhalla AK, Choudhary NS, Chawla YK, Dhiman RK, Dixit VK, Gopalakrishnan N, Gupta A, Hegde UN, Jasuja S, Jha V, Kher V, Kumar A, Madan K, Maiwall R, Mathur RP, Nayak SL, Pandey G, Pandey R, Puri P, Rai RR, Raju SB, Rana DS, Rao PN, Rathi M, Saraswat VA, Saxena S, Shalimar, Sharma P, Singh SP, Singal AK, Soin AS, Taneja S, Varughese S. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease. J Clin Exp Hepatol 2021;11:354-86. [PMID: 33994718 DOI: 10.1016/j.jceh.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Kedarisetty CK, Bhargav VY, Karthikeyan M, Venkataraman J, Sathiyasekaran BWC. Wilson Disease Presenting as Acute on Chronic Liver Failure: A Mystery yet to be Solved!! J Clin Exp Hepatol 2020;10:529-30. [PMID: 33029060 DOI: 10.1016/j.jceh.2020.04.013] [Reference Citation Analysis]
128 Marciano S, Mauro E, Giunta D, Torres MC, Diaz JM, Bermudez C, Gutierrez-Acevedo MN, Narvaez A, Ortíz J, Dirchwolf M, Pollarsky F, Rojas-Saunero LP, Gadano A. Impact of acute-on-chronic liver failure on post-transplant survival and on kidney outcomes. Eur J Gastroenterol Hepatol 2019;31:1157-64. [PMID: 31385871 DOI: 10.1097/MEG.0000000000001467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
129 Zhu B, You S, Rong Y, Yu Q, Lv S, Song F, Liu H, Wang H, Zhao J, Li D, Liu W, Xin S. A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure. Braz J Med Biol Res 2020;53:e9728. [PMID: 33053116 DOI: 10.1590/1414-431X20209728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Ye J, Wu Y, Li M, Gong X, Zhong B. Keratin 8 Mutations Were Associated With Susceptibility to Chronic Hepatitis B and Related Progression. J Infect Dis 2020;221:464-73. [PMID: 31515557 DOI: 10.1093/infdis/jiz467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Qiang L, Qin J, Sun C, Sheng Y, Chen W, Qiu B, Chen X, Chen Y, Liu F, Wu G. A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol 2020;20:301. [PMID: 32938405 DOI: 10.1186/s12876-020-01437-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
132 Guo Y, Zhu Z, Wu W, Huang D, Zheng H, Xu Z, Li X, Wang N, Qin J, Liu Y, Liu L, Nashan B. Liver Transplantation in a Patient With Acute-on-Chronic Liver Failure Due to Traditional Chinese Medicine Intoxication Using Donation After Circulatory Death From a Renal Transplant Recipient: A Case Report. Transplant Proc 2020;52:2813-6. [PMID: 32900476 DOI: 10.1016/j.transproceed.2020.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Arshad A, Irshad L, Nabavi T, Whitehouse T. Acute-on-chronic liver failure: to admit to intensive care or not? Br J Hosp Med (Lond) 2020;81:1-6. [PMID: 32990068 DOI: 10.12968/hmed.2020.0310] [Reference Citation Analysis]
134 Kanda T, Sasaki R, Masuzaki R, Takahashi H, Mizutani T, Matsumoto N, Nirei K, Moriyama M. Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease. Int J Mol Sci 2020;21:E6384. [PMID: 32887515 DOI: 10.3390/ijms21176384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
135 Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment. JHEP Rep 2021;3:100176. [PMID: 33205036 DOI: 10.1016/j.jhepr.2020.100176] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
136 Kumar A, Gupta R, Gupta R. Prevalence of RLS among subjects with chronic liver disease and its effect on sleep and mood. Sleep Medicine 2020;73:144-52. [DOI: 10.1016/j.sleep.2020.05.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
137 Fung J, Mak LY, Chan AC, Chok KS, Wong TC, Cheung TT, Dai WC, Sin SL, She WH, Ma KW, Seto WK, Lai CL, Lo CM, Yuen MF. Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis B. Hepatology 2020;72:818-28. [PMID: 31872444 DOI: 10.1002/hep.31086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
138 Arora V, Vijayaraghavan R, Maiwall R, Sahney A, Thomas SS, Ali R, Jain P, Kumar G, Sarin SK. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure. Hepatology 2020;72:1043-55. [PMID: 31849085 DOI: 10.1002/hep.31071] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
139 Farias AQ, Bittencourt PL. Acute-on-Chronic Liver Failure: Which Definition Is Appropriate in Latin America? Clin Liver Dis (Hoboken) 2020;16:114-6. [PMID: 33005392 DOI: 10.1002/cld.945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Lin S, Yan YY, Wu YL, Wang MF, Zhu YY, Wang XZ. Development of a novel score for the diagnosis of bacterial infection in patients with acute-on-chronic liver failure. World J Gastroenterol 2020; 26(32): 4857-4865 [PMID: 32921962 DOI: 10.3748/wjg.v26.i32.4857] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Sharma S, Agarwal S, Gopi S, Anand A, Mohta S, Gunjan D, Yadav R, Saraya A. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids. J Clin Exp Hepatol 2021;11:171-80. [PMID: 33746441 DOI: 10.1016/j.jceh.2020.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
142 Stotts MJ, Lisman T, Intagliata NM. The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis. Semin Thromb Hemost 2020;46:716-23. [PMID: 32820482 DOI: 10.1055/s-0040-1715449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
143 Sahu D, Bishwal SC, Malik MZ, Sahu S, Kaushik SR, Sharma S, Saini E, Arya R, Rastogi A, Sharma S, Sen S, Singh RKB, Nanda RK, Panda AK. Troxerutin acts on complement mediated inflammation to ameliorate arthritic symptoms in rats.. [DOI: 10.1101/2020.08.18.253427] [Reference Citation Analysis]
144 Zhou C, Zhang N, He TT, Wang Y, Wang LF, Sun YQ, Jing J, Zhang JJ, Fu SN, Wang X, Liang XX, Li X, Gong M, Li J. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(30): 4479-4488 [PMID: 32874059 DOI: 10.3748/wjg.v26.i30.4479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
145 Wang S, Xiong H, Luo C, Zhao H, Fan Y, Zhang T, Wang L, Wang Q, Xie W. Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study. Gastroenterol Res Pract 2020;2020:9831687. [PMID: 32849869 DOI: 10.1155/2020/9831687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
146 Ji D, Zhang D, Yang T, Mu J, Zhao P, Xu J, Li C, Cheng G, Wang Y, Chen Z, Qin E, Lau G. Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020;14:701-710. [PMID: 32734407 DOI: 10.1007/s12072-020-10058-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 17.5] [Reference Citation Analysis]
147 Iwata T, Inoue J, Kakazu E, Ninomiya M, Sano A, Tsuruoka M, Kume K, Masamune A. Rapid enlargement of a hepatic hilar cyst leading to bile duct obstruction after acute exacerbation of chronic hepatitis B. Clin J Gastroenterol 2020;13:1247-51. [PMID: 32729100 DOI: 10.1007/s12328-020-01189-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Fuhrmann V, Weber T, Roedl K, Motaabbed J, Tariparast A, Jarczak D, de Garibay APR, Kluwe J, Boenisch O, Herkner H, Kellum JA, Kluge S. Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure. Ann Intensive Care 2020;10:96. [PMID: 32676849 DOI: 10.1186/s13613-020-00714-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
149 Zhu Z, Yu Y, Ke Y, Deng D, Zheng G, Hua X, Gao G. Thromboelastography maximum amplitude predicts short-term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. Exp Ther Med. 2020;20:2657-2664. [PMID: 32765759 DOI: 10.3892/etm.2020.8990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
150 Jia Y, Shu X, Yang X, Sun H, Cao H, Zhang K, Xu Q, Li G, Yang Y. Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis. Stem Cell Res Ther. 2020;11:277. [PMID: 32650827 DOI: 10.1186/s13287-020-01787-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
151 Gao R, Li Y, Cao Y, Zheng R, Tang L, Yang J, Lu X. Glucocorticoid versus traditional therapy for hepatitis B virus-related acute-on-chronic liver failure: A systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20604. [PMID: 32569189 DOI: 10.1097/MD.0000000000020604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
152 Tang X, Qi T, Li B, Li H, Huang Z, Zhu Z, Tu M, Gao J, Zhu C, Jiang X, Yu X, Lu G, Xiong M, He Q, Zhou F, Wen W, Chen J, Hou J. Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology Organization. J Gastroenterol Hepatol 2021;36:208-16. [PMID: 32445263 DOI: 10.1111/jgh.15113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
153 Xu X, Hou Z, Xu Y, Gu H, Liang G, Huang Y. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol 2021;45:101482. [PMID: 32600902 DOI: 10.1016/j.clinre.2020.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
154 Chen L, Cao Z, Yan L, Ding Y, Shen X, Liu K, Xiang X, Xie Q, Zhu C, Bao S, Wang H. Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome. Front Physiol 2020;11:526. [PMID: 32655398 DOI: 10.3389/fphys.2020.00526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
155 Xiao C, Gong J, Zhu S, Zhang Z, Xi S, Chong Y, Jie Y, Zhang Q. Nomogram based on blood lipoprotein for estimation of mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. BMC Gastroenterol 2020;20:188. [PMID: 32539733 DOI: 10.1186/s12876-020-01324-w] [Reference Citation Analysis]
156 Wong F. Latest Treatment of Acute Kidney Injury in Cirrhosis. Curr Treat Options Gastro 2020;18:281-94. [DOI: 10.1007/s11938-020-00292-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Dong X, He J, Chen W, Su R, Xu Y, Sheng X, Li L, Cao H. Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria. Sci Rep 2020;10:8577. [PMID: 32444697 DOI: 10.1038/s41598-020-65529-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Chen BH, Tseng HJ, Chen WT, Chen PC, Ho YP, Huang CH, Lin CY. Comparing Eight Prognostic Scores in Predicting Mortality of Patients with Acute-On-Chronic Liver Failure Who Were Admitted to an ICU: A Single-Center Experience. J Clin Med. 2020;9. [PMID: 32443729 DOI: 10.3390/jcm9051540] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
159 Zhang K, Lin S, Wang M, Huang J, Zhu Y. The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment. Biomed Res Int 2020;2020:5728359. [PMID: 32596332 DOI: 10.1155/2020/5728359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Liu H, Zhang Q, Liu L, Cao Y, Ye Q, Liu F, Liang J, Wen J, Li Y, Han T. Effect of artificial liver support system on short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Artif Organs 2020;44:E434-47. [PMID: 32320491 DOI: 10.1111/aor.13710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
161 Schmid S, Scherm S, Haderer M, Gülow K, Müller-schilling M. Infektionen bei Leberzirrhose – von bakterieller Translokation über spontan-bakterielle Peritonitis und Pneumonie zum akut-auf-chronischen Leberversagen. Gastroenterologe 2020;15:201-210. [DOI: 10.1007/s11377-020-00439-6] [Reference Citation Analysis]
162 Yoon EL, Kim TY, Lee CH, Kim TH, Cho HC, Lee SS, Kim SE, Kim HY, Kim CW, Song DS, Yang JM, Sinn DH, Jung YK, Yim HJ, Kim HS, Sohn JH, Kim JH, Choe WH, Lee BS, Kim MY, Jeong SW, Choi E, Kim DJ; Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group. Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors. J Clin Gastroenterol 2019;53:134-41. [PMID: 29369242 DOI: 10.1097/MCG.0000000000000987] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
163 Bihari C, Patil A, Shasthry SM, Baweja S, Kumar G, Sarin SK. Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients. Hepatol Int 2020;14:597-608. [PMID: 32304090 DOI: 10.1007/s12072-020-10036-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Li Q, Lu Q, Zhu MQ, Huang C, Yu KK, Huang YX, Zhao X, Luo XG, Zheng JM. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure. BMC Gastroenterol 2020;20:106. [PMID: 32293297 DOI: 10.1186/s12876-020-01258-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
165 Hao J, Qi T, Zhu X, Chen J. Comparative Proteomic Analyses of the Liver in D-Galactosamine-Sensitized Mice Treated with Different Toll-Like Receptor Agonists. Proteomics 2020;20:e1900393. [PMID: 32131144 DOI: 10.1002/pmic.201900393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Liu CR, Li YP, Feng DD, Dang SS. Hot topics and difficult problems in diagnosis and treatment of end-stage liver disease with fungal infection. Shijie Huaren Xiaohua Zazhi 2020; 28(6): 203-209 [DOI: 10.11569/wcjd.v28.i6.203] [Reference Citation Analysis]
167 Zhang X, Ying Y, Zhou P, Liu X, Li R, Tao Y, Dong M, Zhu B, Qi X, Wang Q, Zhang X, Wu J, Zheng J, Zhao W, Zhang W, Wang Z, Zhang J, Huang Y. A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation. Dig Dis Sci 2021;66:284-95. [PMID: 32140946 DOI: 10.1007/s10620-020-06149-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Olson JC. Acute-on-chronic liver failure: management and prognosis. Curr Opin Crit Care 2019;25:165-70. [PMID: 30676328 DOI: 10.1097/MCC.0000000000000595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
169 Kim J, Chung SJ, Sinn DH, Lee KW, Park JB, Huh W, Lee JE, Jang HR, Kang W, Gwak G, Paik Y, Choi MS, Lee JH, Koh KC, Paik SW. Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen‐negative, core antibody‐positive recipients. J Viral Hepat 2020;27:739-46. [DOI: 10.1111/jvh.13279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
170 Devarbhavi H, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C, Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, Treeprasertsuk S, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, Abbas Z, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, Kedarisetty CK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients. Am J Gastroenterol. 2019;114:929-937. [PMID: 31021832 DOI: 10.14309/ajg.0000000000000201] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
171 Arora V, Maiwall R, Rajan V, Jindal A, Muralikrishna Shasthry S, Kumar G, Jain P, Sarin SK. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure. Hepatology 2020;71:600-10. [PMID: 30076614 DOI: 10.1002/hep.30208] [Cited by in Crossref: 71] [Cited by in F6Publishing: 80] [Article Influence: 35.5] [Reference Citation Analysis]
172 Rosenblatt R, Shen N, Tafesh Z, Cohen‐mekelburg S, Crawford CV, Kumar S, Lucero C, Brown RS, Jesudian A, Fortune BE. The North American Consortium for the Study of End‐Stage Liver Disease–Acute‐on‐Chronic Liver Failure Score Accurately Predicts Survival: An External Validation Using a National Cohort. Liver Transpl 2019;26:187-95. [DOI: 10.1002/lt.25696] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
173 Kulkarni AV, Kumar P, Rao NP, Reddy N. Terlipressin-induced ischaemic skin necrosis. BMJ Case Rep 2020;13:e233089. [PMID: 31948983 DOI: 10.1136/bcr-2019-233089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
174 Tong JJ, Zhao W, Mu XY, Xu X, Su HB, Liu XY, Chen J, Zhai XR, Wang Y, Hu JH. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Chin Med J (Engl) 2019;132:1541-9. [PMID: 31188162 DOI: 10.1097/CM9.0000000000000298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Shalimar, Sharma S, Gamanagatti SR, Chauhan A, Vuyyuru SK, Elhence A, Rout G, Saraya A, Gunjan D, Nayak B, Kumar R, Acharya SK. Acute-on-Chronic Liver Failure in Budd–Chiari Syndrome: Profile and Predictors of Outcome. Dig Dis Sci 2020;65:2719-29. [DOI: 10.1007/s10620-019-06005-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
176 Glass DM, Al-khafaji A. The Clinical Spectrum and Manifestations of Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
177 Hudacko R, Cristelli R, Fyfe B. The Pathology of Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_3] [Reference Citation Analysis]
178 Dellatore P, Mishra A, Rustgi V. Prognostic Models in Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_5] [Reference Citation Analysis]
179 Vijayaraghavan R, Sarin SK. Drug-Induced Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_11] [Reference Citation Analysis]
180 Arroyo V, Clària J, Trebicka J. Liver Failure, Acute-on-Chronic. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65780-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Sy AM, O’brien CB. Viral Hepatitis B, C and D in ALF and ALF/CLD. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_9] [Reference Citation Analysis]
182 Brumer R, Navabi S, Pyrsopoulos N. Looking Past Orthotopic Liver Transplantation: A Review of Emerging Strategies for Managing Acute and Acute-on-Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_17] [Reference Citation Analysis]
183 Lin S, Han L, Li D, Wang T, Wu Z, Zhang H, Xiao Z, Wu Y, Huang J, Wang M, Zhu Y. The Association between Meteorological Factors and the Prevalence of Acute-on-chronic Liver Failure: A Population-based Study, 2007-2016. J Clin Transl Hepatol 2019;7:341-5. [PMID: 31915603 DOI: 10.14218/JCTH.2019.00044] [Reference Citation Analysis]
184 Mahmud N, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS. Risk prediction scores for acute on chronic liver failure development and mortality. Liver Int 2020;40:1159-67. [PMID: 31840390 DOI: 10.1111/liv.14328] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
185 Shen G, Sun S, Huang J, Deng H, Xu Y, Wang Z, Tang X, Gong X. Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure. Hepatol Int. 2020;14:47-56. [PMID: 31872330 DOI: 10.1007/s12072-019-10008-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
186 Tomescu D, Popescu M, Biancofiore G. Liver transplantation for acute-on-chronic liver failure. Best Pract Res Clin Anaesthesiol 2020;34:25-33. [PMID: 32334784 DOI: 10.1016/j.bpa.2019.12.001] [Reference Citation Analysis]
187 Choudhary NS, Saraf N, Saigal S, Soin AS. Letter to the Editor: Incidence and Mortality of Acute on Chronic Liver Failure Using Two Definitions in Patients With Compensated Cirrhosis. Hepatology 2019;70:2235-6. [PMID: 31243777 DOI: 10.1002/hep.30837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 Kim PH, Kim JW, Gwon DI, Ko GY, Shin JH, Yoon HK. Embolization for delayed arterial bleeding after percutaneous self-expandable metallic stent placement in patients with malignant biliary obstruction. Br J Radiol 2020;93:20190637. [PMID: 31778313 DOI: 10.1259/bjr.20190637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
189 Xiao LL, Xu XW, Huang KZ, Zhao YL, Zhang LJ, Li LJ. Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis. Biomed Res Int 2019;2019:3757149. [PMID: 31871940 DOI: 10.1155/2019/3757149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
190 Huang PH, Liao CC, Chen MH, Huang TL, Chen CL, Ou HY, Cheng YF. Noncontrast Magnetic Resonance Angiography Clinical Application in Pre-Liver Transplant Recipients With Impaired Renal Function. Liver Transpl 2020;26:196-202. [PMID: 31715655 DOI: 10.1002/lt.25677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
191 Huang K, Ji F, Xie Z, Wu D, Xu X, Gao H, Ouyang X, Xiao L, Zhou M, Zhu D, Li L. Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis. Sci Rep 2019;9:16462. [PMID: 31712684 DOI: 10.1038/s41598-019-53029-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
192 Anand L, Choudhary A, Sarin SK. Reply. Hepatology 2019;70:1873-4. [PMID: 31121059 DOI: 10.1002/hep.30784] [Reference Citation Analysis]
193 Hoppmann NA, Gray ME, McGuire BM. Drug-Induced Liver Injury in the Setting of Chronic Liver Disease. Clin Liver Dis 2020;24:89-106. [PMID: 31753253 DOI: 10.1016/j.cld.2019.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
194 Yu W, Lan X, Cai J, Wang X, Liu X, Ye X, Yang Q, Su Y, Xu B, Chen T, Li L, Sun H. Critical role of IL-1β in the pathogenesis of Agrocybe aegerita galectin-induced liver injury through recruiting T cell to liver. Biochem Biophys Res Commun 2020;521:449-56. [PMID: 31676068 DOI: 10.1016/j.bbrc.2019.10.087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
195 Jayaraman T, Lee YY, Chan WK, Mahadeva S. Epidemiological differences of common liver conditions between Asia and the West. JGH Open. 2020;4:332-339. [PMID: 32514433 DOI: 10.1002/jgh3.12275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
196 Chen T, Yang Z, Choudhury AK, Al Mahtab M, Li J, Chen Y, Tan SS, Han T, Hu J, Hamid SS, Huei LG, Ghazinian H, Nan Y, Chawla YK, Yuen MF, Devarbhavi H, Shukla A, Abbas Z, Sahu M, Dokmeci AK, Lesmana LA, Lesmana CRA, Xin S, Duan Z, Guo W, Ma K, Zhang Z, Cheng Q, Jia J, Sharma BC, Sarin SK, Ning Q. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int. 2019;13:695-705. [PMID: 31650510 DOI: 10.1007/s12072-019-09992-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
197 Sharma S, Lal SB, Sachdeva M, Bhatia A, Varma N. Role of Granulocyte Colony Stimulating Factor on the Short-Term Outcome of Children with Acute on Chronic Liver Failure. J Clin Exp Hepatol 2020;10:201-10. [PMID: 32405176 DOI: 10.1016/j.jceh.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
198 Kilonzo SB, Wang YL, Jiang QQ, Wu WY, Wang P, Ning Q, Han MF. Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B. Curr Med Sci 2019;39:719-26. [PMID: 31612388 DOI: 10.1007/s11596-019-2097-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
199 Li TP, Guan SH, Wang Q, Chen LW, Yang K, Zhang H. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2019; 25(37): 5667-5675 [PMID: 31602166 DOI: 10.3748/wjg.v25.i37.5667] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
200 Alshamsi F, Alshammari K, Belley-Cote E, Dionne J, Albrahim T, Albudoor B, Ismail M, Al-Judaibi B, Baw B, Subramanian RM, Steadman R, Galusca D, Huang DT, Nanchal R, Al Quraini M, Yuan Y, Alhazzani W; GUIDE Group. Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med 2020;46:1-16. [PMID: 31588983 DOI: 10.1007/s00134-019-05783-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
201 Wang X, Xu H, Wang Y, Shen C, Ma L, Zhao C. MicroRNA-124a contributes to glucocorticoid resistance in acute-on-chronic liver failure by negatively regulating glucocorticoid receptor alpha. Ann Hepatol 2020;19:214-21. [PMID: 31628069 DOI: 10.1016/j.aohep.2019.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
202 Wei X, Yu H, Zhao P, Xie L, Li L, Zhang J. Serum regucalcin is a useful indicator of liver injury severity in patients with hepatitis B virus-related liver diseases. Braz J Med Biol Res 2019;52:e8845. [PMID: 31576907 DOI: 10.1590/1414-431X20198845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
203 Ray G, Manjubhargav P. Clinical Presentation and Mortality Determinants of Alcohol-Related Liver Disease: A Single-Center Experience of the Rising Menace from Eastern India. Inflamm Intest Dis 2019;4:104-14. [PMID: 31559262 DOI: 10.1159/000501274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
204 Kumar M, Kainth S, Choudhury A, Maiwall R, Mitra LG, Saluja V, Agarwal PM, Shasthry SM, Jindal A, Bhardwaj A, Kumar G, Sarin SK. Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial. Hepatol Int 2019;13:800-13. [DOI: 10.1007/s12072-019-09986-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
205 Shubham S, Kumar D, Rooge S, Maras JS, Maheshwari D, Nautiyal N, Kumari R, Bhat A, Kumar G, Rastogi A, Kumar S, Pamecha V, Maiwall R, Bihari C, Kumar A, Sarin SK. Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure. Hepatol Int 2019;13:777-87. [PMID: 31515741 DOI: 10.1007/s12072-019-09983-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
206 Sedano R, Castro L, Venegas M, Miranda J, Hurtado C, Poniachik J, Brahm J. Liver transplantation in acute liver failure due to Hepatitis B. Two clinical cases. Ann Hepatol 2021;21:100107. [PMID: 31623992 DOI: 10.1016/j.aohep.2019.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Kabbani AR, Tergast TL, Manns MP, Maasoumy B. [Treatment strategies for acute-on-chronic liver failure]. Med Klin Intensivmed Notfmed 2021;116:3-16. [PMID: 31463674 DOI: 10.1007/s00063-019-00613-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
208 Wang C, Ma DQ, Luo S, Wang CM, Ding DP, Tian YY, Ao KJ, Zhang YH, Chen Y, Meng ZJ. Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2019; 7(16): 2204-2216 [PMID: 31531315 DOI: 10.12998/wjcc.v7.i16.2204] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
209 Wang C, Ma D, Luo S, Wang C, Ding D, Tian Y, Ao K, Zhang Y, Chen Y, Meng Z. Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. WJCC 2019;7:2204-16. [DOI: 10.12998/wjge.v7.i16.2204] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
210 Lai R, Chen T, Wu Z, Lin S, Zhu Y. Associations between body mass index and mortality in acute-on-chronic liver failure patients. Ann Hepatol. 2019;18:893-897. [PMID: 31506215 DOI: 10.1016/j.aohep.2019.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
211 Smolka V, Tkachyk O, Ehrmann J, Karaskova E, Zapalka M, Volejnikova J. Acute onset of autoimmune hepatitis in children and adolescents. Hepatobiliary Pancreat Dis Int 2020;19:17-21. [PMID: 31474443 DOI: 10.1016/j.hbpd.2019.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
212 Zhang X, Dong P, Xu L, Tian Y, Sun H, Shi H, Duan Z, Chen L, Ren F. The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure. BMC Gastroenterol 2019;19:148. [PMID: 31429707 DOI: 10.1186/s12876-019-1064-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
213 Jindal A, Mukund A, Kumar G, Sarin SK. Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis. Liver Int. 2019;39:2164-2173. [PMID: 31356712 DOI: 10.1111/liv.14200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
214 Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Siam Tan S, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab MA, Ghazinyan H, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, Lesmana LA, Lesmana CR, Sollano JD, Carpio G, Sahu MK, Kumar G, Sarin SK; APASL ACLF (APASL ACLF Research Consortium) Working Party. Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy. Hepatology 2019;70:587-96. [PMID: 30113706 DOI: 10.1002/hep.30205] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
215 Cai Q, Zhu M, Duan J, Wang H, Sheng J. Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis. J Int Med Res 2019;47:4492-504. [PMID: 31364441 DOI: 10.1177/0300060519862065] [Reference Citation Analysis]
216 Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand? World J Gastroenterol 2019; 25(28): 3684-3703 [PMID: 31391766 DOI: 10.3748/wjg.v25.i28.3684] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
217 Lin S, Yan Y, Wu Y, Van Poucke S, Wang M, Zhu Y, Wang X. Procalcitonin as a biomarker for diagnose of bacterial infection in patients with acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol. 2020;44:e32-e34. [PMID: 31303532 DOI: 10.1016/j.clinre.2019.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
218 Cao Z, Liu Y, Wang S, Lu X, Yin S, Jiang S, Chen L, Cai M, Zeng B, Yao Y, Tang W, Zhao G, Xiang X, Wang H, Cai W, Zhu C, Li H, Xie Q. The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infection. Liver Int. 2019;39:1943-1953. [PMID: 31206235 DOI: 10.1111/liv.14176] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
219 Maipang K, Potranun P, Chainuvati S, Nimanong S, Chotiyaputta W, Tanwandee T, Charatcharoenwitthaya P. Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults. PLoS One 2019;14:e0219516. [PMID: 31291342 DOI: 10.1371/journal.pone.0219516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
220 Chen P, Wang YY, Chen C, Guan J, Zhu HH, Chen Z. The immunological roles in acute-on-chronic liver failure: An update. Hepatobiliary Pancreat Dis Int 2019;18:403-11. [PMID: 31303562 DOI: 10.1016/j.hbpd.2019.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
221 Cai Q, Liu W, Zhu M, Sheng J. Microbial Infections as a Trigger for Acute-on-Chronic Liver Failure: A Review. Med Sci Monit 2019;25:4773-83. [PMID: 31282874 DOI: 10.12659/MSM.915637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
222 Ran X, Zhang QF, Luo L, Zhang DZ, Li W. The Efficacy and Safety of Glucocorticoids Plus Conventional Therapy for Hepatitis B-Related Liver Failure in China: A Meta-Analysis. Hepat Mon 2019;19. [DOI: 10.5812/hepatmon.65787] [Reference Citation Analysis]
223 Lin S, Wu B, Lin Y, Wang M, Zhu Y, Jiang J, Zhang L, Lin J. Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure. Biomed Res Int 2019;2019:9145736. [PMID: 31317042 DOI: 10.1155/2019/9145736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
224 Shukla A, Jain A. Association of acute-on-chronic liver failure with vascular liver diseases. Hepatol Int 2019;13:399-402. [PMID: 31172418 DOI: 10.1007/s12072-019-09958-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
225 Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Song DS, Yang JM, Yoon EL;  APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353-390. [PMID: 31172417 DOI: 10.1007/s12072-019-09946-3] [Cited by in Crossref: 257] [Cited by in F6Publishing: 283] [Article Influence: 85.7] [Reference Citation Analysis]
226 Xue R, Yang J, Jia L, Zhu X, Wu J, Zhu Y, Meng Q. Mitofusin2, as a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure. Front Pharmacol 2019;10:601. [PMID: 31231215 DOI: 10.3389/fphar.2019.00601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
227 Yuan L, Zeng BM, Liu LL, Ren Y, Yang YQ, Chu J, Li Y, Yang FW, He YH, Lin SD. Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection. World J Gastroenterol 2019; 25(19): 2327-2337 [PMID: 31148904 DOI: 10.3748/wjg.v25.i19.2327] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
228 Cao Z, Chen L, Li J, Liu Y, Bao R, Liu K, Yan L, Ding Y, Guo Q, Xiang X, Xie J, Lin L, Xie Q, Bao S, Wang H. Serum keratin‐18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus‐related cirrhosis. J Viral Hepat 2019;26:835-45. [DOI: 10.1111/jvh.13100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
229 Huang Z, Wang N, Huang S, Chen Y, Yang S, Gan Q, Ye H, Liu B, Pan C. Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. Gastroenterol Res Pract 2019;2019:3467690. [PMID: 31191644 DOI: 10.1155/2019/3467690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Ferreira Cardoso M, Alexandrino G, Carvalho e Branco J, Anapaz V, Carvalho R, Horta D, Martins A. The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study. Gastroenterología y Hepatología (English Edition) 2019;42:296-303. [DOI: 10.1016/j.gastre.2018.11.028] [Reference Citation Analysis]
231 Artru F, Samuel D. Approaches for patients with very high MELD scores. JHEP Reports 2019;1:53-65. [DOI: 10.1016/j.jhepr.2019.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
232 Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis. Hepatology 2019;69:2150-63. [PMID: 30615211 DOI: 10.1002/hep.30494] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 31.0] [Reference Citation Analysis]
233 Ferreira Cardoso M, Alexandrino G, Carvalho e Branco J, Anapaz V, Carvalho R, Horta D, Martins A. The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study. Gastroenterología y Hepatología 2019;42:296-303. [DOI: 10.1016/j.gastrohep.2018.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
234 Lei JH, Peng F, Chen Z, Xiao XQ. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis? BMC Infect Dis 2019;19:363. [PMID: 31039732 DOI: 10.1186/s12879-019-3988-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
235 Wang Z, Wang A, Gong Z, Biviano I, Liu H, Hu J. Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease. Clin Res Hepatol Gastroenterol 2019;43:410-6. [PMID: 31053499 DOI: 10.1016/j.clinre.2018.11.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
236 Huang C, Yu KK, Zheng JM, Li N. Steroid treatment in patients with acute-on-chronic liver failure precipitated by hepatitis B: A 10-year cohort study in a university hospital in East China. J Dig Dis 2019;20:38-44. [PMID: 30515980 DOI: 10.1111/1751-2980.12691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
237 Zhang Y, Li L. State of the art—Artificial liver in China. Artif Organs 2019;43:336-41. [DOI: 10.1111/aor.13448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 Zeng Y, Li Y, Xu Z, Gan W, Lu L, Huang X, Lin C. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure. J Med Virol. 2019;91:1510-1518. [PMID: 30905084 DOI: 10.1002/jmv.25466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
239 Alam S, Lal BB, Sood V, Khanna R, Kumar G. AARC-ACLF score: best predictor of outcome in children and adolescents with decompensated Wilson disease. Hepatol Int 2019;13:330-8. [DOI: 10.1007/s12072-019-09938-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
240 Wang Y, Chen C, Qi J, Wu F, Guan J, Chen Z, Zhu H. Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure. J Transl Med 2019;17:93. [PMID: 30890164 DOI: 10.1186/s12967-019-1844-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
241 Lin S, Zhang K, Zhang J, Wang M, Velani B, Zhu Y. Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study. Liver Int. 2019;39:854-860. [PMID: 30753752 DOI: 10.1111/liv.14072] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
242 Xiong L, Du Y, Zhou T, Du B, Visalath P, Lin L, Bao S, Cai W. N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus. J Gastroenterol Hepatol 2019;34:1800-8. [PMID: 30771232 DOI: 10.1111/jgh.14634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
243 Leão GS, Lunardi FL, Picon RV, Tovo CV, de Mattos AA, de Mattos ÂZ. Acute-on-chronic liver failure: A comparison of three different diagnostic criteria. Annals of Hepatology 2019;18:373-8. [DOI: 10.1016/j.aohep.2019.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
244 Cai JJ, Wang K, Jiang HQ, Han T. Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients. Biomed Res Int 2019;2019:6025726. [PMID: 30937312 DOI: 10.1155/2019/6025726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
245 Macnaughtan J. Acute-on-Chronic Liver Failure: Diagnosis, Prognosis, and Treatment. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch24] [Reference Citation Analysis]
246 Khatua CR, Sahu SK, Barik RK, Pradhan S, Panigrahi S, Mishra D, Singh SP. Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease. JGH Open 2019;3:290-4. [PMID: 31406921 DOI: 10.1002/jgh3.12152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
247 Xue R, Zhu Y, Liu H, Meng Q. The clinical parameters for the diagnosis of hepatitis B virus related acute-on-chronic liver failure with sepsis. Sci Rep 2019;9:2558. [PMID: 30796255 DOI: 10.1038/s41598-019-38866-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
248 Qin J, Qiang L, Chen W, Wu G. [Red blood cell distribution width is a independent prognostic indicator for mortality in patients with HBV related acute-on-chronic liver failure]. Nan Fang Yi Ke Da Xue Xue Bao 2018;38:1354-9. [PMID: 30514685 DOI: 10.12122/j.issn.1673-4254.2018.11.13] [Reference Citation Analysis]
249 Yao J, Li S, Zhou L, Luo L, Yuan L, Duan Z, Xu J, Chen Y. Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure. J Clin Apher 2019;34:392-8. [PMID: 30758886 DOI: 10.1002/jca.21690] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
250 Wang SJ, Yin S, Gu WY, Zhang Y, Li H. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis. J Dig Dis 2018;19:614-25. [PMID: 30226019 DOI: 10.1111/1751-2980.12671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
251 Xu WX, He HL, Pan SW, Chen YL, Zhang ML, Zhu S, Gao ZL, Peng L, Li JG. Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China. Stem Cells Int. 2019;2019:4130757. [PMID: 30863450 DOI: 10.1155/2019/4130757] [Cited by in Crossref: 18] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
252 Taneja D, Tyagi SS. Impact of SSL Enabled Collaboration Tool on Clinical Research. 2019 International Conference on Machine Learning, Big Data, Cloud and Parallel Computing (COMITCon) 2019. [DOI: 10.1109/comitcon.2019.8862262] [Reference Citation Analysis]
253 Qi T, Zhu C, Lu G, Hao J, He Q, Chen Y, Zhou F, Chen J, Hou J. Elevated D-dimer is associated with increased 28-day mortality in acute-on-chronic liver failure in China: a retrospective study. BMC Gastroenterol 2019;19:20. [PMID: 30704397 DOI: 10.1186/s12876-019-0941-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
254 Sun Z, Liu X, Wu D, Gao H, Jiang J, Yang Y, Wu J, Gao Q, Wang J, Jiang Z, Xu Y, Xu X, Li L. Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B. Theranostics 2019;9:1200-14. [PMID: 30867825 DOI: 10.7150/thno.31991] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
255 Lei P, Shen G, Wang F, Ning Q, Ren H, Yan W, Wu D. Immunological Features of AECHB. Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1606-0_5] [Reference Citation Analysis]
256 Wang Y, Li K, Dou X, Bai H, Zhao X, Ma X, Li L, Chen Z, Huang Y. Treatment of AECHB and Severe Hepatitis (Liver Failure). Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1603-9_4] [Reference Citation Analysis]
257 Chen Z, Ning Q, Chen G. Early Prognostic Predictive System of AECHB and the Diagnosis of Severe Hepatitis B (Liver Failure). Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1603-9_3] [Reference Citation Analysis]
258 Ning Q, Wu T, Su H, Ma K, Qi J, Ni M, Wu D. Antiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure). Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1603-9_5] [Reference Citation Analysis]
259 Ning Q, Wu D, Guo W, Li W, Wang X, Ma K. Introduction to Acute Exacerbation of Chronic Hepatitis B (AECHB). Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1606-0_1] [Reference Citation Analysis]
260 Lei J, Zeng YL, Xu LY, Wang Y. Analysis of Treatment of 3 Patients with Acute-on-Chronic Liver Failure. Case Rep Med 2018;2018:7421502. [PMID: 30595700 DOI: 10.1155/2018/7421502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
261 Maschmeier M, Hüsing-kabar A, Schmidt HH. Acute-On-Chronic Liver Failure. Critical Care for Potential Liver Transplant Candidates 2019. [DOI: 10.1007/978-3-319-92934-7_11] [Reference Citation Analysis]
262 Lu J, Lin L, Ye C, Tao Q, Cui M, Zheng S, Zhu D, Liu L, Xue Y. Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure. Annals of Hepatology 2019;18:155-64. [DOI: 10.5604/01.3001.0012.7907] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
263 Xu X, Bai Z, Zhao Q, Li H, Shi Q, Deng J, Zhang J, Guo X, Qi X. Successful Pharmacotherapy for Multiple Acute Decompensation Events in a Cirrhotic Patient with Acute-on-chronic Liver Failure: A Case Report. J Transl Int Med 2018;6:189-93. [PMID: 30637207 DOI: 10.2478/jtim-2018-0035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
264 Khatua CR, Panigrahi S, Mishra D, Pradhan S, Sahu SK, Barik RK, Parida PK, Behera S, Parida S, Singh SP. Acute Kidney Injury at Admission Is a Better Predictor of Mortality than Its Persistence at 48 h in Patients with Acute-on-chronic Liver Failure. J Clin Transl Hepatol 2018;6:396-401. [PMID: 30637217 DOI: 10.14218/JCTH.2018.00035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
265 Artzner T, Michard B, Besch C, Levesque E, Faitot F. Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals. World J Gastroenterol 2018; 24(46): 5203-5214 [PMID: 30581269 DOI: 10.3748/wjg.v24.i46.5203] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
266 Garcia-Tsao G. Acute-on-Chronic Liver Failure: An Old Entity in Search of Clarity. Hepatol Commun 2018;2:1421-4. [PMID: 30556031 DOI: 10.1002/hep4.1287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
267 Wu T, Li J, Shao L, Xin J, Jiang L, Zhou Q, Shi D, Jiang J, Sun S, Jin L, Ye P, Yang L, Lu Y, Li T, Huang J, Xu X, Chen J, Hao S, Chen Y, Xin S, Gao Z, Duan Z, Han T, Wang Y, Gan J, Feng T, Pan C, Chen Y, Li H, Huang Y, Xie Q, Lin S, Li L, Li J; Chinese Group on the Study of Severe Hepatitis B (COSSH). Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut 2018;67:2181-91. [PMID: 28928275 DOI: 10.1136/gutjnl-2017-314641] [Cited by in Crossref: 132] [Cited by in F6Publishing: 143] [Article Influence: 33.0] [Reference Citation Analysis]
268 Finkenstedt A, Effenberger M, Zoller H. Lebertransplantation: Indikationen und Abklärung. J Gastroenterol Hepatol Erkr 2018;16:112-120. [DOI: 10.1007/s41971-018-0038-6] [Reference Citation Analysis]
269 Sun Z, Chang B, Huang A, Hao S, Gao M, Sun Y, Shi M, Jin L, Zhang W, Zhao J, Teng G, Han L, Tian H, Liang Q, Zhang JY, Zou Z. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease. J Cell Mol Med 2019;23:887-97. [PMID: 30478965 DOI: 10.1111/jcmm.13990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
270 Cai J, Wang K, Han T, Jiang H. Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2018;97:e13324. [PMID: 30431619 DOI: 10.1097/MD.0000000000013324] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
271 Dong R, Wan B, Lin S, Wang M, Huang J, Wu Y, Wu Y, Zhang N, Zhu Y. Procalcitonin and Liver Disease: A Literature Review. J Clin Transl Hepatol. 2019;7:51-55. [PMID: 30944820 DOI: 10.14218/jcth.2018.00012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
272 Hu J, Zhao H, Lou D, Gao H, Yang M, Zhang X, Jia H, Li L. Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure. BMC Infect Dis 2018;18:577. [PMID: 30445927 DOI: 10.1186/s12879-018-3488-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
273 Tripathi DM, Vilaseca M, Lafoz E, Garcia-Calderó H, Viegas Haute G, Fernández-Iglesias A, Rodrigues de Oliveira J, García-Pagán JC, Bosch J, Gracia-Sancho J. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension. Gastroenterology 2018;155:1564-77. [PMID: 30055171 DOI: 10.1053/j.gastro.2018.07.022] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 17.3] [Reference Citation Analysis]
274 Zhang GL, Zhang T, Zhao QY, Lin CS, Gao ZL. Th17 cells over 5.9% at admission indicate poor prognosis in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2018;97:e12656. [PMID: 30290645 DOI: 10.1097/MD.0000000000012656] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
275 Waseem N, Limketkai BN, Kim B, Woreta T, Gurakar A, Chen PH. Risk and Prognosis of Acute Liver Injury Among Hospitalized Patients with Hemodynamic Instability: A Nationwide Analysis. Ann Hepatol 2018;17:119-24. [PMID: 29311395 DOI: 10.5604/01.3001.0010.7543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
276 Yan Q, Wang L, Lai L, Liu S, Chen H, Zhang J, Dai Y, Sui W. Next generation sequencing reveals novel alterations in B-cell heavy chain receptor repertoires associated with acute-on-chronic liver failure. Int J Mol Med. 2019;43:243-255. [PMID: 30365073 DOI: 10.3892/ijmm.2018.3946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
277 Lal BB, Sood V, Khanna R, Alam S. How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure? Hepatol Int 2018;12:552-9. [PMID: 30341639 DOI: 10.1007/s12072-018-9901-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
278 Zhao R, Wu W, Zhou Z, Zheng X, Sun W, Shi Y, Yu H, Wang F, Zhao H, Sun S, Jin L, Sheng J, Shi Y. Prognostic utility of novel biomarkers in acute-on-chronic liver failure (ACLF) associated with hepatitis B: A multicenter prospective study. Hepatol Res 2019;49:42-50. [PMID: 30246902 DOI: 10.1111/hepr.13251] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
279 Chen EQ, Shimakami T, Fan YC, Angeli P. Acute-on-Chronic Liver Failure: From Basic Research to Clinical Applications. Can J Gastroenterol Hepatol 2018;2018:5029789. [PMID: 30402449 DOI: 10.1155/2018/5029789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
280 Verma N, Kaur A, Sharma R, Bhalla A, Sharma N, De A, Singh V. Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: A randomized trial. Hepatology 2018;68:1559-73. [PMID: 29278428 DOI: 10.1002/hep.29763] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
281 Tsai YW, Tzeng IS, Chen YC, Hsieh TH, Chang SS. Survival prediction among patients with non-cancer-related end-stage liver disease. PLoS One 2018;13:e0202692. [PMID: 30240398 DOI: 10.1371/journal.pone.0202692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
282 Tao YC, Wang ML, Wang M, Ma YJ, Bai L, Feng P, Chen EQ, Tang H. Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure. Dig Liver Dis 2019;51:412-8. [PMID: 30274791 DOI: 10.1016/j.dld.2018.08.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
283 Bai Z, Li H, Guo X, Liu Y, Deng J, Wang C, Li Y, Qi X. Successful treatment of acute-on-chronic liver failure and hemolytic anemia with hepato-protective drugs in combination with intravenous ozone without steroids: A case report. Intractable Rare Dis Res 2018;7:204-8. [PMID: 30181943 DOI: 10.5582/irdr.2018.01074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
284 Li C, Zhu B, Lv S, You S, Xin S. Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure. Medicine (Baltimore) 2018;97:e11915. [PMID: 30142800 DOI: 10.1097/MD.0000000000011915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
285 Gu WY, Xu BY, Zheng X, Chen J, Wang XB, Huang Y, Gao YH, Meng ZJ, Qian ZP, Liu F, Lu XB, Shang J, Li H, Wang SY, Sun X, Li H. Acute-on-Chronic Liver Failure in China: Rationale for Developing a Patient Registry and Baseline Characteristics. Am J Epidemiol 2018;187:1829-39. [PMID: 29762630 DOI: 10.1093/aje/kwy083] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
286 Li F, Li Y, Fan Y, Wang K. Plasma concentration of diamine oxidase (DAO) predicts 1-month mortality of acute-on-chronic hepatitis B liver failure. Clinica Chimica Acta 2018;484:164-70. [DOI: 10.1016/j.cca.2018.05.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
287 Gao F, Zhang Q, Liu Y, Gong G, Mao D, Gong Z, Li J, Luo X, Li X, Chen G, Li Y, Zhao W, Wan G, Li H, Sun K, Wang X. Nomogram prediction of individual prognosis of patients with acute-on-chronic hepatitis B liver failure. Dig Liver Dis. 2019;51:425-433. [PMID: 30241795 DOI: 10.1016/j.dld.2018.08.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
288 Tseng Y, Li F, Wang J, Chen S, Jiang W, Shen X, Wu S. Spleen and liver stiffness for noninvasive assessment of portal hypertension in cirrhotic patients with large esophageal varices. J Clin Ultrasound. 2018;46:442-449. [PMID: 30132919 DOI: 10.1002/jcu.22635] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
289 Sarin SK, Choudhury A. Management of acute-on-chronic liver failure: an algorithmic approach. Hepatol Int 2018;12:402-16. [PMID: 30116993 DOI: 10.1007/s12072-018-9887-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
290 Engelmann C, Berg T. Modulation der Immunreaktion kann Organdysfunktionen bei ACLF reduzieren. Gastro-News 2018;5:48-52. [DOI: 10.1007/s15036-018-0420-4] [Reference Citation Analysis]
291 Satsangi S, Duseja A, Sachdeva M, Tomer S, Arora SK, Taneja S, Dhiman RK, Chawla YK. Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure. PLoS One 2018;13:e0200644. [PMID: 30020985 DOI: 10.1371/journal.pone.0200644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
292 Bai Z, Li H, Zheng K, Zhang J, Zhang X, Deng J, Jia Z, Zhou X, Guo X, Qi X. A good response to glucocorticoid for sub-acute liver failure: a case report. Transl Gastroenterol Hepatol 2018;3:25. [PMID: 29971256 DOI: 10.21037/tgh.2018.04.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
293 Wu C, Zhu Y, Yu M. Serum Metabonomics Analysis of Liver Failure Treated by Nonbioartificial Liver Support Systems. Can J Gastroenterol Hepatol. 2018;2018:2586052. [PMID: 30073154 DOI: 10.1155/2018/2586052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
294 Lange CM, Moreau R. Immunodysfunction in Acute-on-Chronic Liver Failure. Visc Med 2018;34:276-82. [PMID: 30345285 DOI: 10.1159/000488690] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
295 Chen L, Bao D, Gu L, Gu Y, Zhou L, Gao Z, Huang Y. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infect Dis 2018;18:295. [PMID: 29970037 DOI: 10.1186/s12879-018-3192-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
296 Steve RJ, Gnanadurai FJ, Anantharam R, Jeyaseelan V, Zachariah UG, Goel A, Chundamannil EE, Abraham P. Expanded Diagnostic Approach to Hepatitis E Virus Detection in Patients with Acute-on-Chronic Liver Failure: A Pilot Study. Indian Journal of Medical Microbiology 2018;36:391-6. [DOI: 10.4103/ijmm.ijmm_18_35] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
297 Frias M, López-López P, Rivero A, Rivero-Juarez A. Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure. Biomed Res Int 2018;2018:9098535. [PMID: 30050945 DOI: 10.1155/2018/9098535] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
298 Sood V, Lal BB, Rawat D, Khanna R, Rastogi A, Bihari C, Kumar G, Alam S. Spectrum of Pediatric Autoimmune Liver Disease and Validation of Its Diagnostic Scores in Indian Children. J Pediatr Gastroenterol Nutr 2018;67:e65-72. [PMID: 29901555 DOI: 10.1097/MPG.0000000000002050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
299 Huebener P, Sterneck M, Fuhrmann V. Editorial: transplantation in the setting of acute-on-chronic liver failure-calculating chances. Authors' reply. Aliment Pharmacol Ther 2018;48:100-1. [PMID: 29882978 DOI: 10.1111/apt.14804] [Reference Citation Analysis]
300 Jiang QQ, Han MF, Ma K, Chen G, Wan XY, Kilonzo SB, Wu WY, Wang YL, You J, Ning Q. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis. World J Gastroenterol 2018; 24(21): 2300-2310 [PMID: 29881239 DOI: 10.3748/wjg.v24.i21.2300] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
301 Cheng YL, Chang CH, Chen WT, Tsai MH, Lee WC, Tu KH, Tian YC, Chen YC, Hung CC, Fang JT, Yang CW, Chang MY. Prognostic factors and treatment effect of standard-volume plasma exchange for acute and acute-on-chronic liver failure: A single-center retrospective study. Transfus Apher Sci. 2018;57:537-543. [PMID: 29880246 DOI: 10.1016/j.transci.2018.05.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
302 O'Leary JG, Reddy KR, Garcia-Tsao G, Biggins SW, Wong F, Fallon MB, Subramanian RM, Kamath PS, Thuluvath P, Vargas HE, Maliakkal B, Tandon P, Lai J, Thacker LR, Bajaj JS. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology 2018;67:2367-74. [PMID: 29315693 DOI: 10.1002/hep.29773] [Cited by in Crossref: 138] [Cited by in F6Publishing: 141] [Article Influence: 34.5] [Reference Citation Analysis]
303 Mostafa EF, Ismael WA, Hawary AE, Marei A, Saber S. Hepatic microcirculatory thrombosis in acute-on-chronic hepatic failure. Egypt J Intern Med 2018;30:83-89. [DOI: 10.4103/ejim.ejim_5_18] [Reference Citation Analysis]
304 Yao J, Zhou X, Wang H, Yuan L, Chen Y, Duan Z. Persistently Increased Resting Energy Expenditure Predicts Short-Term Mortality in Patients with Acute-on-Chronic Liver Failure. Ann Nutr Metab 2018;73:2-9. [PMID: 29788014 DOI: 10.1159/000487604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
305 Zhou T, Sun Y, Li M, Ding Y, Yin R, Li Z, Xie Q, Bao S, Cai W. Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway. Cell Death Dis 2018;9:590. [PMID: 29789597 DOI: 10.1038/s41419-018-0670-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
306 Wang X, Shen C, Yang J, Yang X, Qin S, Zeng H, Wu X, Tang S, Zeng W. Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. Can J Gastroenterol Hepatol 2018;2018:1232785. [PMID: 29854714 DOI: 10.1155/2018/1232785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
307 Jie Y, Gong J, Xiao C, Zhu S, Zhou W, Luo J, Chong Y, Hu B. Low Platelet to White Blood Cell Ratio Indicates Poor Prognosis for Acute-On-Chronic Liver Failure. Biomed Res Int 2018;2018:7394904. [PMID: 29854786 DOI: 10.1155/2018/7394904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
308 Xu XL. Value of cystatin C, β2 macroglobulin, serum creatinine, and blood urea nitrogen in predicting hepatorenal syndrome in patients with acute-on-chronic liver failure. Shijie Huaren Xiaohua Zazhi 2018; 26(12): 700-706 [DOI: 10.11569/wcjd.v26.i12.700] [Reference Citation Analysis]
309 Chen N, Chen X, Ding X, Teng J. Analysis of the high incidence of acute kidney injury associated with acute-on-chronic liver failure. Hepatol Int 2018;12:262-8. [DOI: 10.1007/s12072-018-9866-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
310 Cao Y, Zhang B, Lin R, Wang Q, Wang J, Shen F. Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option. Gastroenterol Res Pract 2018;2018:9231710. [PMID: 29686702 DOI: 10.1155/2018/9231710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
311 Jin JY, Zheng YB, Zheng J, Liu J, Mao YJ, Chen SG, Gao ZL, Zheng RQ. 2D shear wave elastography combined with MELD improved prognostic accuracy in patients with acute-on-chronic hepatitis B liver failure. Eur Radiol 2018;28:4465-74. [PMID: 29696433 DOI: 10.1007/s00330-018-5336-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
312 Ma Y, Xu Y, Chen F, Wang Y, Bai L, Tang H. Good Tolerance of Citrate Accumulation due to Plasma Exchange among Patients with Acute-on-Chronic Liver Failure: A Prospective, Observational Study. Can J Gastroenterol Hepatol 2018;2018:4909742. [PMID: 29850456 DOI: 10.1155/2018/4909742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
313 Yin S, Wang SJ, Gu WY, Zhang Y, Chen LY, Li H. Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients. J Dig Dis 2017;18:292-301. [PMID: 28485081 DOI: 10.1111/1751-2980.12480] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
314 Huang KW, Tam KW, Luo JC, Kuan YC. Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus-related Acute Exacerbation and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2017;51:539-47. [PMID: 28067752 DOI: 10.1097/MCG.0000000000000675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
315 Liu L, Xiao D, Yu JH, Shen R, Wang M, Li Q. Clinical course of sporadic acute hepatitis E in a hepatitis B virus endemic region. Int J Infect Dis 2018;70:107-14. [PMID: 29551632 DOI: 10.1016/j.ijid.2018.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
316 Ren Y, Liu L, Li Y, Yang F, He Y, Zhu Y, Hu X, Lin S. Development and validation of a scoring system to predict progression to acute-on-chronic liver failure in patients with acute exacerbation of chronic hepatitis B. Hepatol Res. 2018;48:692-700. [PMID: 29336092 DOI: 10.1111/hepr.13062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
317 Mochida S, Nakayama N, Ido A, Inoue K, Genda T, Takikawa Y, Sakaida I, Terai S, Yokosuka O, Shimizu M, Takikawa H. Proposed diagnostic criteria for acute-on-chronic liver failure in Japan. Hepatol Res. 2018;48:219-224. [PMID: 29361652 DOI: 10.1111/hepr.13066] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
318 Nakayama N, Uemura H, Uchida Y, Tomiya T, Ido A, Inoue K, Genda T, Takikawa Y, Sakaida I, Terai S, Yokosuka O, Shimizu M, Takikawa H, Mochida S. A multicenter pilot survey to clarify the clinical features of patients with acute-on-chronic liver failure in Japan. Hepatol Res. 2018;48:303-312. [PMID: 29341357 DOI: 10.1111/hepr.13064] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
319 Lin L, Yang F, Wang Y, Su S, Su Z, Jiang X, Zheng Y, Deng Y, Lv H, Zhao J, Lin R, Wang B, Sun C. Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis. International Immunopharmacology 2018;56:58-64. [DOI: 10.1016/j.intimp.2018.01.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
320 Xi RR, Han T, Lv JY, Cai JJ. Comparison of five different scoring models for predicting short-term mortality in patients with alcohol-related acute-on-chronic liver failure. Shijie Huaren Xiaohua Zazhi 2018; 26(6): 365-372 [DOI: 10.11569/wcjd.v26.i6.365] [Reference Citation Analysis]
321 Zheng YX, Zhong X, Li YJ, Fan XG. Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32:1668-1678. [PMID: 28303605 DOI: 10.1111/jgh.13786] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
322 Song DS, Kim TY, Kim DJ, Kim HY, Sinn DH, Yoon EL, Kim CW, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Choe WH, Yim HJ, Kim SE, Baik SK, Jang JY, Kim HS, Kim SG, Yang JM, Sohn JH, Choi EH, Cho HC, Jeong SW, Kim MY;  Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group. Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure. J Gastroenterol Hepatol. 2018;33:900-909. [PMID: 28921629 DOI: 10.1111/jgh.13991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
323 Yuan S, Qian Y, Tan D, Mo D, Li X. Therapeutic plasma exchange: A prospective randomized trial to evaluate 2 strategies in patients with liver failure. Transfus Apher Sci. 2018;57:253-258. [PMID: 29571962 DOI: 10.1016/j.transci.2018.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
324 Lal BB, Alam S, Sood V, Rawat D, Khanna R. Profile, risk factors and outcome of acute kidney injury in paediatric acute-on-chronic liver failure. Liver Int 2018;38:1777-84. [PMID: 29325220 DOI: 10.1111/liv.13693] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
325 Pang SY, Dai YM, Zhang RZ, Chen YH, Peng XF, Fu J, Chen ZR, Liu YF, Yang LY, Wen Z, Yu JK, Liu HY. Autoimmune liver disease-related autoantibodies in patients with biliary atresia. World J Gastroenterol 2018; 24(3): 387-396 [PMID: 29391761 DOI: 10.3748/wjg.v24.i3.387] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
326 Zhao RH, Shi Y, Zhao H, Wu W, Sheng JF. Acute-on-chronic liver failure in chronic hepatitis B: an update. Expert Rev Gastroenterol Hepatol 2018;12:341-50. [PMID: 29334786 DOI: 10.1080/17474124.2018.1426459] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
327 Huang GQ, Xie YY, Zhu PW, Wang XD, Lin Z, Wang Y, Ye JP, Wang YM, Chen YX, Jin XZ, Van Poucke S, Chen YP, Zheng MH. Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure. Expert Rev Gastroenterol Hepatol 2018;12:295-302. [PMID: 29300103 DOI: 10.1080/17474124.2018.1424540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
328 Chattopadhyay TK. Advances in Gastrointestinal Surgery. GI Surgery Annual 2018. [DOI: 10.1007/978-981-13-0161-2_8] [Reference Citation Analysis]
329 Mochida S, Nakayama N, Ido A, Inoue K, Genda T, Takikawa Y, Sakaida I, Terai S, Yokosuka O, Shimizu M, Takikawa H. Proposal of Diagnostic Criteria for Acute-On-Chronic Liver Failure (ACLF) in Japan. Acta hepatologica Japonica 2018;59:155-61. [DOI: 10.2957/kanzo.59.155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
330 Dellavolpe J, Kim M, Bleck TP, Al-khafaji A. Cerebrovascular Physiology in Liver Disease. Hepatic Critical Care 2018. [DOI: 10.1007/978-3-319-66432-3_6] [Reference Citation Analysis]
331 Torres HA, Hosry J, Mahale P, Economides MP, Jiang Y, Lok AS. Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study. Hepatology 2018;67:36-47. [PMID: 28653760 DOI: 10.1002/hep.29344] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 18.3] [Reference Citation Analysis]
332 Kumar A, Sood V, Khanna R, Verma SK, Mehra N, Rawat D, Alam S. Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury. Indian J Pediatr 2018;85:676-8. [PMID: 29247427 DOI: 10.1007/s12098-017-2570-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
333 Liu L, Lu J, Ye C, Lin L, Zheng S, Zhang H, Lan Q, Xue Y. Serum osteopontin is a predictor of prognosis for HBV-associated acute-on-chronic liver failure. Biomed Rep 2018;8:166-71. [PMID: 29435276 DOI: 10.3892/br.2017.1027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
334 Qin G, Shao JG, Zhu YC, Xu AD, Yao JH, Wang XL, Qian YK, Wang HY, Shen Y, Lu P, Wang LJ. Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study. J Clin Gastroenterol. 2016;50:670-675. [PMID: 27136963 DOI: 10.1097/mcg.0000000000000538] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
335 Taneja S, Duseja A, Bhatia A, Nada R, Vishwajeet V. Metabolic Syndrome with Double Hit, Nonproteinuric Diabetic Nephropathy and Nonalcoholic Steatohepatitis-related Cirrhosis: Autopsy Findings. Journal of Postgraduate Medicine, Education and Research 2017;51:195-206. [DOI: 10.5005/jp-journals-10028-1263] [Reference Citation Analysis]
336 Liu L, Lan Q, Lin L, Lu J, Ye C, Tao Q, Cui M, Zheng S, Zhang X, Xue Y. Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failure. Clin Chim Acta 2018;476:92-7. [PMID: 29170103 DOI: 10.1016/j.cca.2017.11.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
337 Alam S, Lal BB, Sood V, Rawat D. Pediatric Acute-on-Chronic Liver Failure in a Specialized Liver Unit: Prevalence, Profile, Outcome, and Predictive Factors. J Pediatr Gastroenterol Nutr. 2016;63:400-405. [PMID: 26967824 DOI: 10.1097/mpg.0000000000001179] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
338 Xue R, Duan Z, Liu H, Chen L, Yu H, Ren M, Zhu Y, Jin C, Han T, Gao Z, Meng Q. A novel dynamic model for predicting outcome in patients with hepatitis B virus related acute-on-chronic liver failure. Oncotarget. 2017;8:108970-108980. [PMID: 29312583 DOI: 10.18632/oncotarget.22447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
339 Simonetto DA, Shah VH, Kamath PS. Improving survival in ACLF: growing evidence for use of G-CSF. Hepatol Int 2017;11:473-5. [PMID: 29124667 DOI: 10.1007/s12072-017-9834-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
340 Lin SD, Ren Y, Liu LL. Identification and management of patients with severe exacerbation of chronic hepatitis B. Shijie Huaren Xiaohua Zazhi 2017; 25(31): 2747-2753 [DOI: 10.11569/wcjd.v25.i31.2747] [Reference Citation Analysis]
341 Li YH, Xu Y, Wu HM, Yang J, Yang LH, Yue-Meng W. Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study. Stem Cell Rev Rep. 2016;12:645-653. [PMID: 27687792 DOI: 10.1007/s12015-016-9683-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 8.8] [Reference Citation Analysis]
342 Gao S, Joshi SS, Osiowy C, Chen Y, Coffin CS, Duan ZP. Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants. Virol J. 2017;14:203. [PMID: 29065883 DOI: 10.1186/s12985-017-0870-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
343 Wong F. Acute-on-Chronic Liver Failure. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch18] [Reference Citation Analysis]
344 Mönkemüller K, Schwingel GE, Martinez-alcala A, Jovanovic I. Endoscopic Retrograde Cholangiopancreatography and Cholangioscopy in Hepatobiliary Disease. Endoscopy in Liver Disease 2017. [DOI: 10.1002/9781118660799.ch12] [Reference Citation Analysis]
345 Maiwall R, Kumar G, Bharadwaj A, Jamwal K, Bhadoria AS, Jain P, Sarin SK. AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure. Hepatol Int 2017;11:529-39. [PMID: 28983839 DOI: 10.1007/s12072-017-9822-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
346 Ibáñez-samaniego L, Bañares R. Acute on chronic liver failure: Are we ready to predict? Liver Int 2017;37:1449-1450. [DOI: 10.1111/liv.13483] [Reference Citation Analysis]
347 Cai J, Zhang M, Han T, Jiang HQ. Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure. Medicine (Baltimore). 2017;96:e8057. [PMID: 28906399 DOI: 10.1097/md.0000000000008057] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
348 Lin S, Chen J, Wang M, Han L, Zhang H, Dong J, Zeng D, Jiang J, Zhu Y. Prognostic nomogram for acute-on-chronic hepatitis B liver failure. Oncotarget. 2017;8:109772-109782. [PMID: 29312647 DOI: 10.18632/oncotarget.21012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
349 Choudhury A, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, Mahtab M, Rahman S, Chawla YK, Taneja S, Tan SS, Devarbhavi H, Duan Z, Yu C, Ning Q, Jia JD, Amarapurkar D, Eapen CE, Goel A, Hamid SS, Butt AS, Jafri W, Kim DJ, Ghazinian H, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Dokmeci AK, Sollano JD, Carpio G, Lau GK, Karim F, Rao PN, Moreau R, Jain P, Bhatia P, Kumar G, Sarin SK; APASL ACLF Working Party. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int 2017;11:461-71. [PMID: 28856540 DOI: 10.1007/s12072-017-9816-z] [Cited by in Crossref: 95] [Cited by in F6Publishing: 72] [Article Influence: 19.0] [Reference Citation Analysis]
350 Mohan N, Karkra S, Rastogi A, Dhaliwal MS, Raghunathan V, Goyal D, Goja S, Bhangui P, Vohra V, Piplani T, Sharma V, Gautam D, Baijal SS, Soin AS. Outcome of 200 pediatric living donor liver transplantations in India. Indian Pediatr 2017;54:913-8. [DOI: 10.1007/s13312-017-1181-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
351 Choudhary NS, Saraf N, Saigal S, Soin AS. Liver Transplantation for Acute on Chronic Liver Failure. J Clin Exp Hepatol 2017;7:247-52. [PMID: 28970712 DOI: 10.1016/j.jceh.2017.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
352 Kang TW, Kim M, Kim YK, Kim SH, Sinn DH, Kim K. The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure. Clin Imaging 2018;47:18-24. [PMID: 28818763 DOI: 10.1016/j.clinimag.2017.08.004] [Reference Citation Analysis]
353 Maiwall R, Jamwal KD, Bhardwaj A, Bhadoria AS, Maras JS, Kumar G, Jindal A, Choudhury A, Anand L, Sahney A, Kumar A, Sharma MK, Sharma BC, Sarin SK. SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure. Dig Dis Sci 2018;63:493-501. [PMID: 28780608 DOI: 10.1007/s10620-017-4686-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
354 王宪波, 高方媛. 慢加急性肝衰竭: 东西方诊断和预后的差异. 世界华人消化杂志 2017; 25(21): 1910-1920 [DOI: 10.11569/wcjd.v25.i21.1910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
355 Li X, Gao F, Liu H, Zhang H, Liu Y, Ye X, Geng M, Sun L, Wang R, Li Y. Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score. Eur J Gastroenterol Hepatol. 2017;29:1-9. [PMID: 27749778 DOI: 10.1097/meg.0000000000000750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
356 Wu W, Yan H, Zhao H, Sun W, Yang Q, Sheng J, Shi Y. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: Differentiate it from No-ACLF. Liver Int. 2018;38:248-257. [PMID: 28646630 DOI: 10.1111/liv.13504] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
357 Wu J, Li YY, Hu JH, Jia L, Shi M, Meng FP, Li J, Zhao J, Wang FS, Meng QH. Differential characteristics and prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure defined by European Association for the Study of the Liver - Chronic Liver Failure criteria. Hepatol Res 2018;48:153-64. [PMID: 28456135 DOI: 10.1111/hepr.12909] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
358 Wang X, Wu W, Qiu G, Wang H, Li W, Wang Y, Jiang Q, Han M, Ning Q. Plasma lipidomics identifies novel biomarkers in patients with hepatitis B virus-related acute-on-chronic liver failure. Metabolomics 2017;13:76. [DOI: 10.1007/s11306-017-1215-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
359 Li N, Huang C, Yu KK, Lu Q, Shi GF, Zheng JM. Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF. Medicine (Baltimore). 2017;96:e6802. [PMID: 28445322 DOI: 10.1097/md.0000000000006802] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
360 Gao F, Wang R, Deng H, Hou F, Romeiro FG, Qi X. Liver-to-abdominal area ratio for predicting the in-hospital mortality in advanced liver cirrhosis. Postgrad Med 2017;129:756-61. [PMID: 28486857 DOI: 10.1080/00325481.2017.1327781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
361 Yang D, Xie Y, Pan H, Huang Y, Dai Y, Tong Y, Chen M. Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome. Hepatol Res. 2017;47:1174-1185. [PMID: 28249358 DOI: 10.1111/hepr.12886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
362 Duseja A, Singh SP. Toward a Better Definition of Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 2017;7:262-5. [PMID: 28970714 DOI: 10.1016/j.jceh.2017.05.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
363 Nayak SL, Kumar M, Bihari C, Rastogi A. Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study. J Clin Transl Hepatol. 2017;5:92-100. [PMID: 28660146 DOI: 10.14218/jcth.2016.00063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
364 Chen R, Wang X, Dong J, Lin Z, Wu J, Cai Y, Shi K. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure. Clinica Chimica Acta 2017;468:195-200. [DOI: 10.1016/j.cca.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
365 Khanam A, Trehanpati N, Riese P, Rastogi A, Guzman CA, Sarin SK. Blockade of Neutrophil's Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure. Front Immunol 2017;8:464. [PMID: 28484461 DOI: 10.3389/fimmu.2017.00464] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
366 Ganesh R, Suresh N, Vasanthi T, Sathiyasekaran M, Thulasiraman R. A 6-year-old boy with Wilson disease-A diagnostic dilemma.Indian J Gastroenterol. 2017;36:149-154. [PMID: 28435998 DOI: 10.1007/s12664-017-0746-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
367 Lai J, Liu Y, Pan C, Lin C, Sun F, Huang Z, Lin Y, Zhou R, Lin Y, Zhou Y. Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure. Exp Ther Med 2017;13:2867-75. [PMID: 28587352 DOI: 10.3892/etm.2017.4361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
368 Chen EQ, Wang ML, Zhang DM, Shi Y, Wu DB, Yan LB, Du LY, Zhou LY, Tang H. Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure. Sci Rep 2017;7:45576. [PMID: 28358016 DOI: 10.1038/srep45576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
369 Cai YJ, Dong JJ, Dong JZ, Chen Y, Lin Z, Song M, Wang YQ, Chen YP, Shi KQ, Zhou MT. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure. Aliment Pharmacol Ther. 2017;45:1413-1426. [PMID: 28345155 DOI: 10.1111/apt.14046] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
370 Bao S, Zhao Q, Zheng J, Li N, Huang C, Chen M, Cheng Q, Zhu M, Yu K, Liu C, Shi G. Interleukin-23 mediates the pathogenesis of LPS/GalN-induced liver injury in mice. Int Immunopharmacol 2017;46:97-104. [PMID: 28282579 DOI: 10.1016/j.intimp.2017.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
371 Hernaez R, Solà E, Moreau R, Ginès P. Acute-on-chronic liver failure: an update. Gut 2017;66:541-53. [PMID: 28053053 DOI: 10.1136/gutjnl-2016-312670] [Cited by in Crossref: 339] [Cited by in F6Publishing: 350] [Article Influence: 67.8] [Reference Citation Analysis]
372 Shi K, Cai Y, Lin Z, Dong J, Wu J, Wang X, Song M, Wang Y, Chen Y. Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure: Prognostic nomogram for liver failure. Journal of Gastroenterology and Hepatology 2017;32:497-505. [DOI: 10.1111/jgh.13502] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
373 Hübener P, Braun G, Fuhrmann V. [Acute-on-chronic liver failure: a diagnostic and therapeutic challenge for intensive care]. Med Klin Intensivmed Notfmed 2018;113:649-57. [PMID: 28210759 DOI: 10.1007/s00063-017-0263-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
374 Luo Y, Xu Y, Li M, Xie Y, Gong G. A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2016;95:e4696. [PMID: 27559979 DOI: 10.1097/MD.0000000000004696] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
375 Weng W, Shi Y, Peng X, Xiong J, Cao H, Lin B. The Association between Expression of NK Cells and Prognosis of Patients with HBV Acute-on-Chronic Liver Failure in Advanced Phase. AID 2017;07:118-125. [DOI: 10.4236/aid.2017.74012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
376 Bao S, Zheng J, Li N, Huang C, Chen M, Cheng Q, Li Q, Lu Q, Zhu M, Ling Q, Yu K, Chen S, Shi G. Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage. Clin Res Hepatol Gastroenterol. 2017;41:147-155. [PMID: 28041935 DOI: 10.1016/j.clinre.2016.10.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
377 Xu R, Bao C, Huang H, Lin F, Yuan Y, Wang S, Jin L, Yang T, Shi M, Zhang Z, Wang FS. Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure. Sci Rep 2016;6:38714. [PMID: 27974825 DOI: 10.1038/srep38714] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
378 Bao Q, Wang B, Yu L, Weng H, Ge J, Li L. A modified prognostic score for critically ill patients with cirrhosis: An observational study. J Gastroenterol Hepatol 2016;31:450-8. [PMID: 26251873 DOI: 10.1111/jgh.13076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
379 Prasanna KS, Goel A, Amirtharaj GJ, Ramachandran A, Balasubramanian KA, Mackie I, Zachariah U, Sajith KG, Elias E, Eapen CE. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure. Indian J Gastroenterol 2016;35:432-40. [DOI: 10.1007/s12664-016-0708-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
380 Jindal A, Rastogi A, Sarin SK. Reviewing the diagnostic criteria for acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol 2016;10:1385-95. [PMID: 27771965 DOI: 10.1080/17474124.2016.1250622] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
381 Saraswat V, Singh SP, Duseja A, Shukla A, Eapen CE, Kumar D, Pandey G, Venkataraman J, Puri P, Narayanswami K, Dhiman RK, Thareja S, Nijhawan S, Bhatia S, Zachariah U, Sonika U, Varghese T, Acharya SK; Shalimar. Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience: ACLF-Indian experience. Journal of Gastroenterology and Hepatology 2016;31:1742-9. [DOI: 10.1111/jgh.13340] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
382 Sarin SK, Choudhury A. Acute-on-chronic Liver Failure. Curr Gastroenterol Rep 2016;18. [DOI: 10.1007/s11894-016-0535-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
383 Shi K, Zhou Y, Yan H, Li H, Wu F, Xie Y, Braddock M, Lin X, Zheng M. Classification and regression tree analysis of acute-on-chronic hepatitis B liver failure: Seeing the forest for the trees. J Viral Hepat 2017;24:132-40. [DOI: 10.1111/jvh.12617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
384 Kumar D, Pandey G, Bansal D, Rawat A, Kumar U, Dubey D, Guleria A, Saraswat VA. NMR-based urinary profiling of lactulose/mannitol ratio used to assess the altered intestinal permeability in acute on chronic liver failure (ACLF) patients: Altered intestinal permeability in ACLF patients assessed by 1 H NMR. Magn Reson Chem 2017;55:289-96. [DOI: 10.1002/mrc.4525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
385 Anand AC, Dhiman RK. Acute on Chronic Liver Failure-What is in a 'Definition'? J Clin Exp Hepatol 2016;6:233-40. [PMID: 27746620 DOI: 10.1016/j.jceh.2016.08.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
386 Zheng QF, Li JS, Bai L, Zheng SJ. Protective effect of liver fibrosis against acute liver injury. Shijie Huaren Xiaohua Zazhi 2016; 24(24): 3537-3542 [DOI: 10.11569/wcjd.v24.i24.3537] [Reference Citation Analysis]
387 Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.Int J Cancer. 2016;139:2519-2528. [PMID: 27501007 DOI: 10.1002/ijc.30372] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
388 Sun FK, Gao S, Fan YC, Shi CH, Zhang ZH, Wang LY, Li F, Li XY, Ji XF, Zhao J, Wang K. High promoter methylation levels of glutathione-S-transferase M3 predict poor prognosis of acute-on-chronic hepatitis B liver failure. Hepatol Res 2017;47:566-73. [PMID: 27442719 DOI: 10.1111/hepr.12777] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
389 Zang H, Liu F, Liu H, You S, Zhu B, Wan Z, Xin S. Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis. Hepatol Int 2016;10:807-18. [DOI: 10.1007/s12072-016-9756-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
390 Hu T, Yao L, Hu A, Jiang S, Ying H, Deng Q, Hu Y, Zhou W, Xiong T. Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure: Nucleos(t)ide analogs improve prognosis. Hepatol Res 2017;47:347-58. [DOI: 10.1111/hepr.12755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
391 Zheng QF, Zhang JY, Wu JS, Zhang Y, Liu M, Bai L, Zhang JY, Zhao J, Chen Y, Duan ZP, Zheng SJ. Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Prospective Study. Medicine (Baltimore) 2016;95:e2639. [PMID: 26871786 DOI: 10.1097/MD.0000000000002639] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
392 Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016;2:16041. [PMID: 27277335 DOI: 10.1038/nrdp.2016.41] [Cited by in Crossref: 214] [Cited by in F6Publishing: 223] [Article Influence: 35.7] [Reference Citation Analysis]
393 Qin G, Bian ZL, Shen Y, Zhang L, Zhu XH, Liu YM, Shao JG. Logistic regression model can reduce unnecessary artificial liver support in hepatitis B virus-associated acute-on-chronic liver failure: decision curve analysis. BMC Med Inform Decis Mak 2016;16:59. [PMID: 27260306 DOI: 10.1186/s12911-016-0302-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
394 Haga Y, Yasui S, Kanda T, Hattori N, Wakamatsu T, Nakamura M, Sasaki R, Wu S, Nakamoto S, Arai M, Maruyama H, Ohtsuka M, Oda S, Miyazaki M, Yokosuka O. Successful Management of Acute Liver Failure Patients Waiting for Liver Transplantation by On-Line Hemodiafiltration with an Arteriovenous Fistula. Case Rep Gastroenterol. 2016;10:139-145. [PMID: 27403116 DOI: 10.1159/000445186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
395 Peng Y, Qi X, Tang S, Deng H, Li J, Ning Z, Dai J, Hou F, Zhao J, Wang R, Guo X. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol 2016;10:971-80. [PMID: 27070325 DOI: 10.1080/17474124.2016.1177788] [Cited by in Crossref: 13] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
396 Hong YS, Sinn DH, Gwak GY, Cho J, Kang D, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease. World J Gastroenterol 2016; 22(14): 3785-3792 [PMID: 27076763 DOI: 10.3748/wjg.v22.i14.3785] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
397 Yang J, Sun H, Liu Q. The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2016;2016:5802674. [PMID: 27148364 DOI: 10.1155/2016/5802674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
398 Wang N, Fan YC, Xia HH, Sun YY, Wang K. Plasma interleukin-10 predicts short-term mortality of acute-on-chronic hepatitis B liver failure. Aliment Pharmacol Ther 2016;43:1208-21. [PMID: 27038362 DOI: 10.1111/apt.13603] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
399 Maiwall R, Moreau R. Plasma exchange for acute on chronic liver failure: is there a light at the end of the tunnel? Hepatol Int 2016;10:387-9. [DOI: 10.1007/s12072-016-9703-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
400 Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13:131-149. [PMID: 26837712 DOI: 10.1038/nrgastro.2015.219] [Cited by in Crossref: 186] [Cited by in F6Publishing: 196] [Article Influence: 31.0] [Reference Citation Analysis]
401 Kim TY, Song DS, Kim HY, Sinn DH, Yoon EL, Kim CW, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Choe WH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Suh J 3rd, Kim HS, Nam SW, Kwon HC, Kim YS, Kim SG, Chae HB, Yang JM, Sohn JH, Lee HJ, Park SH, Han BH, Choi EH, Kim CH, Kim DJ; Korean Acute-on-Chronic Liver Failure Study Group. Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition. PLoS One 2016;11:e0146745. [PMID: 26789409 DOI: 10.1371/journal.pone.0146745] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
402 Fan YC, Wang N, Sun YY, Xiao XY, Wang K. TIPE2 mRNA Level in PBMCs Serves as a Novel Biomarker for Predicting Short-Term Mortality of Acute-on-Chronic Hepatitis B Liver Failure: A Prospective Single-Center Study. Medicine (Baltimore) 2015;94:e1638. [PMID: 26426653 DOI: 10.1097/MD.0000000000001638] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
403 Tsai WL, Sun WC, Cheng JS. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int J Mol Sci. 2015;16:28126-28145. [PMID: 26703566 DOI: 10.3390/ijms161226087] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
404 Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, Alonso-López S, Fernández-Rodríguez CM. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol 2015; 21(42): 12125-12140 [PMID: 26576097 DOI: 10.3748/wjg.v21.i42.12125] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
405 Singh H, Pai CG. Defining acute-on-chronic liver failure: East, West or Middle ground? World J Hepatol 2015; 7(25): 2571-2577 [PMID: 26557949 DOI: 10.4254/wjh.v7.i25.2571] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
406 Sun FK, Wang K. Application of glucocorticoids in liver failure. Shijie Huaren Xiaohua Zazhi 2015; 23(29): 4611-4616 [DOI: 10.11569/wcjd.v23.i29.4611] [Reference Citation Analysis]
407 Zhang Q, Han T, Li Y, Nie C, Liu H. Predictors of progression into acute-on-chronic liver failure from acute deterioration of pre-existing chronic liver disease. Hepatol Res. 2016;46:320-328. [PMID: 26234788 DOI: 10.1111/hepr.12567] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
408 Kakisaka K, Kataoka K, Kuroda H, Takikawa Y. Predictive formula for acute liver failure is useful for predicting the prognosis of patients with acute-on-chronic liver failure: A predictive formula for the prognosis of liver failure in ACLF. Hepatol Res 2016;46:459-67. [DOI: 10.1111/hepr.12577] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
409 Maiwall R, Kumar S, Chandel SS, Kumar G, Rastogi A, Bihari C, Sharma MK, Thakur B, Jamwal K, Nayak S, Mathur RP, Sarin SK. AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis. Hepatol Int 2015;9:627-39. [DOI: 10.1007/s12072-015-9653-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
410 Abbas Z, Shazi L. Pattern and profile of chronic liver disease in acute on chronic liver failure. Hepatol Int 2015;9:366-72. [PMID: 26016461 DOI: 10.1007/s12072-015-9627-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
411 Wang X, Sarin SK, Ning Q. Definition of ACLF and inclusion criteria for extra-hepatic organ failure. Hepatol Int 2015;9:360-5. [PMID: 26016465 DOI: 10.1007/s12072-015-9637-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
412 Zhang Q, Li Y, Han T, Nie C, Cai J, Liu H, Liu Y. Comparison of current diagnostic criteria for acute-on-chronic liver failure. PLoS One 2015;10:e0122158. [PMID: 25785855 DOI: 10.1371/journal.pone.0122158] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
413 Mochida S. Recent status of acute liver failure in Japan. Acta hepatologica Japonica 2015;56:453-460. [DOI: 10.2957/kanzo.56.453] [Reference Citation Analysis]
414 Nicaise G, Gillot I, Julliard AK, Keicher E, Blaineau S, Amsellem J, Meyran JC, Hernandez-Nicaise ML, Ciapa B, Gleyzal C. X-ray microanalysis of calcium containing organelles in resin embedded tissue. Scanning Microsc. 1989;3:199-219; discussion 219-220. [PMID: 2662396 DOI: 10.1111/apt.13484] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]